,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,321051,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10036.0,Mesocricetus auratus (golden hamster),Cholesterol results in increased expression of ABCG5 mRNA,,,PMID:15342687,https://www.ncbi.nlm.nih.gov/pubmed/15342687,15342687,,
1,321052,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10090.0,Mus musculus (house mouse),Diosgenin promotes the reaction [ABCG5 protein results in increased secretion of cholesterol]|cholates promotes the reaction [ABCG5 protein results in increased secretion of cholesterol]|abcg5 protein results in increased secretion of cholesterol,,,PMID:15611112,https://www.ncbi.nlm.nih.gov/pubmed/15611112,15611112,,
2,321053,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10090.0,Mus musculus (house mouse),[cholesterol deficiency co-treated with dietary fats] results in decreased expression of ABCG5 mRNA,,,PMID:18356535,https://www.ncbi.nlm.nih.gov/pubmed/18356535,18356535,,
3,321203,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of ABCG5 mrna|[abcg5 protein binds to ABCG8 protein] which affects the transport of cholesterol|cholesterol results in decreased expression of ABCG5 mRNA,,,PMID:15683829,https://www.ncbi.nlm.nih.gov/pubmed/15683829,15683829,,
4,321204,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),Arachidonic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|apoa1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]|pld2 protein affects the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of cholesterol]]|triacsin C inhibits the reaction [linoleic acid inhibits the reaction [ABCA1 protein results in increased transport of cholesterol]]|oleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|mastoparan inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of cholesterol]]|palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|abca1 protein results in increased transport of cholesterol|1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|linoleic acid inhibits the reaction [ABCA1 protein results in increased export of cholesterol]|1-butanol inhibits the reaction [linoleic acid inhibits the reaction [ABCA1 protein results in increased export of cholesterol]]|linoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|pld2 protein inhibits the reaction [linoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of cholesterol]]],,,PMID:16118212,https://www.ncbi.nlm.nih.gov/pubmed/16118212,16118212,,
5,321205,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),ABCA1 protein results in increased export of cholesterol,,,PMID:15983222|PMID:20655299,https://www.ncbi.nlm.nih.gov/pubmed/15983222|https://www.ncbi.nlm.nih.gov/pubmed/20655299,15983222|20655299,,
6,321206,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),Glyoxal inhibits the reaction [ABCA1 protein results in increased export of cholesterol]|apoa1 protein promotes the reaction [ABCA1 protein results in increased export of cholesterol]|glycolaldehyde inhibits the reaction [ABCA1 protein results in increased export of cholesterol],,,PMID:15983222,https://www.ncbi.nlm.nih.gov/pubmed/15983222,15983222,,
7,321207,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),[HCAR2 protein results in decreased expression of ABCA1 protein] which results in decreased export of cholesterol|[[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased expression of ABCA1 protein] which results in decreased export of cholesterol,,,PMID:20655299,https://www.ncbi.nlm.nih.gov/pubmed/20655299,20655299,,
8,321208,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),[resveratrol results in increased expression of ABCA1 protein] which results in increased secretion of cholesterol|abca1 protein results in increased secretion of cholesterol,,,PMID:20372816,https://www.ncbi.nlm.nih.gov/pubmed/20372816,20372816,,
9,321209,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10036.0,Mesocricetus auratus (golden hamster),Cholesterol results in increased expression of ABCA1 mRNA,,,PMID:15342687,https://www.ncbi.nlm.nih.gov/pubmed/15342687,15342687,,
10,321210,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),ABCA1 protein affects the export of cholesterol,,,PMID:14993927,https://www.ncbi.nlm.nih.gov/pubmed/14993927,14993927,,
11,321374,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),ABCA1 protein results in increased export of cholesterol,,,PMID:20655299|PMID:22022523,https://www.ncbi.nlm.nih.gov/pubmed/20655299|https://www.ncbi.nlm.nih.gov/pubmed/22022523,20655299|22022523,,
12,321375,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),[capsaicin results in increased expression of ABCA1 protein] which results in decreased uptake of cholesterol|[capsaicin results in increased expression of ABCA1 protein] which results in increased secretion of cholesterol,,,PMID:21908651,https://www.ncbi.nlm.nih.gov/pubmed/21908651,21908651,,
13,321376,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),[cholesterol co-treated with dietary fats] results in increased expression of ABCA1 mRNA,,,PMID:15694933,https://www.ncbi.nlm.nih.gov/pubmed/15694933,15694933,,
14,321377,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),[cholesterol deficiency co-treated with dietary fats] results in decreased expression of ABCA1 mRNA,,,PMID:18356535,https://www.ncbi.nlm.nih.gov/pubmed/18356535,18356535,,
15,321378,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10090.0,Mus musculus (house mouse),"[[plant preparations co-treated with cholesterol, dietary] results in increased expression of ABCA1 mrna] which results in increased secretion of cholesterol",,,PMID:23900008,https://www.ncbi.nlm.nih.gov/pubmed/23900008,23900008,,
16,321379,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10116.0,Rattus norvegicus (Norway rat),[[colestimide co-treated with pravastatin] results in increased expression of ABCA1 protein] which results in decreased abundance of cholesterol|[cholesterol co-treated with 25-hydroxycholesterol] results in decreased expression of ABCA1 mRNA,,,PMID:17526932,https://www.ncbi.nlm.nih.gov/pubmed/17526932,17526932,,
17,321380,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,10116.0,Rattus norvegicus (Norway rat),Cholesterol inhibits the reaction [bisphenol A results in decreased expression of ABCA1 mrna],,,PMID:28859904,https://www.ncbi.nlm.nih.gov/pubmed/28859904,28859904,,
18,321381,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),ABCA1 protein affects the transport of cholesterol,,,PMID:15883047,https://www.ncbi.nlm.nih.gov/pubmed/15883047,15883047,,
19,321382,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),ABCA1 protein results in increased transport of cholesterol,,,PMID:16530456,https://www.ncbi.nlm.nih.gov/pubmed/16530456,16530456,,
20,321383,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,19,ABCA1,https://ctdbase.org/detail.go?type=gene&acc=19,,,19.0,ABCA1,9606.0,Homo sapiens (human),[IL1B protein results in decreased expression of ABCA1 mrna] which results in increased abundance of cholesterol|[il1b protein results in decreased expression of ABCA1 mrna] which results in decreased transport of cholesterol,,,PMID:12595494,https://www.ncbi.nlm.nih.gov/pubmed/12595494,12595494,,
21,321516,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8647,ABCB11,https://ctdbase.org/detail.go?type=gene&acc=8647,,,8647.0,ABCB11,10090.0,Mus musculus (house mouse),ABCB11 protein results in increased secretion of cholesterol,,,PMID:14570929,https://www.ncbi.nlm.nih.gov/pubmed/14570929,14570929,,
22,321517,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5244,ABCB4,https://ctdbase.org/detail.go?type=gene&acc=5244,,,5244.0,ABCB4,10090.0,Mus musculus (house mouse),ABCB4 protein affects the export of cholesterol,,,PMID:15019087,https://www.ncbi.nlm.nih.gov/pubmed/15019087,15019087,,
23,321518,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,9606.0,Homo sapiens (human),ABCG1 protein results in increased secretion of cholesterol|[resveratrol results in increased expression of ABCG1 protein] which results in increased secretion of cholesterol,,,PMID:20372816,https://www.ncbi.nlm.nih.gov/pubmed/20372816,20372816,,
24,321519,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,10036.0,Mesocricetus auratus (golden hamster),Cholesterol results in increased expression of ABCG1 mRNA,,,PMID:15342687,https://www.ncbi.nlm.nih.gov/pubmed/15342687,15342687,,
25,321520,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,10090.0,Mus musculus (house mouse),HCAR2 protein inhibits the reaction [[niacin results in increased expression of ABCG1 protein] which results in increased export of cholesterol]|[niacin results in increased expression of ABCG1 protein] which results in increased export of cholesterol,,,PMID:21317532,https://www.ncbi.nlm.nih.gov/pubmed/21317532,21317532,,
26,321521,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,9606.0,Homo sapiens (human),ABCG1 affects the export of cholesterol,,,PMID:17194745,https://www.ncbi.nlm.nih.gov/pubmed/17194745,17194745,,
27,321522,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9619,ABCG1,https://ctdbase.org/detail.go?type=gene&acc=9619,,,9619.0,ABCG1,9606.0,Homo sapiens (human),ABCG1 protein affects the export of cholesterol,,,PMID:16024918,https://www.ncbi.nlm.nih.gov/pubmed/16024918,16024918,,
28,321523,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606.0,Homo sapiens (human),Sulfasalazine promotes the reaction [cholesterol results in increased activity of ABCG2 protein]|cholesterol results in increased activity of ABCG2 protein,,,PMID:27475308,https://www.ncbi.nlm.nih.gov/pubmed/27475308,27475308,,
29,321524,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,735312,ABCG2A,https://ctdbase.org/detail.go?type=gene&acc=735312,,,735312.0,abcg2a,8022.0,Oncorhynchus mykiss (rainbow trout),Cholesterol results in increased activity of ABCG2A protein|sulfasalazine affects the reaction [cholesterol results in increased activity of ABCG2A protein],,,PMID:27475308,https://www.ncbi.nlm.nih.gov/pubmed/27475308,27475308,,
30,321525,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,9606.0,Homo sapiens (human),ABCG5 protein affects the export of cholesterol,,,PMID:15696852,https://www.ncbi.nlm.nih.gov/pubmed/15696852,15696852,,
31,321694,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64240,ABCG5,https://ctdbase.org/detail.go?type=gene&acc=64240,,,64240.0,ABCG5,10116.0,Rattus norvegicus (Norway rat),[ethinyl estradiol results in decreased expression of ABCG5 mrna] which results in decreased secretion of cholesterol|[diosgenin results in increased expression of ABCG5 mrna] which results in increased secretion of cholesterol,,,PMID:12963437,https://www.ncbi.nlm.nih.gov/pubmed/12963437,12963437,,
32,321695,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64241,ABCG8,https://ctdbase.org/detail.go?type=gene&acc=64241,,,64241.0,ABCG8,9606.0,Homo sapiens (human),ABCG8 protein affects the export of cholesterol,,,PMID:15696852,https://www.ncbi.nlm.nih.gov/pubmed/15696852,15696852,,
33,321696,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64241,ABCG8,https://ctdbase.org/detail.go?type=gene&acc=64241,,,64241.0,ABCG8,10036.0,Mesocricetus auratus (golden hamster),Cholesterol results in increased expression of ABCG8 mRNA,,,PMID:15342687,https://www.ncbi.nlm.nih.gov/pubmed/15342687,15342687,,
34,321697,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64241,ABCG8,https://ctdbase.org/detail.go?type=gene&acc=64241,,,64241.0,ABCG8,10090.0,Mus musculus (house mouse),Cholates promotes the reaction [ABCG8 protein results in increased secretion of cholesterol]|diosgenin promotes the reaction [ABCG8 protein results in increased secretion of cholesterol]|abcg8 protein results in increased secretion of cholesterol,,,PMID:15611112,https://www.ncbi.nlm.nih.gov/pubmed/15611112,15611112,,
35,321698,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64241,ABCG8,https://ctdbase.org/detail.go?type=gene&acc=64241,,,64241.0,ABCG8,10090.0,Mus musculus (house mouse),[cholesterol deficiency co-treated with dietary fats] results in decreased expression of ABCG8 mRNA,,,PMID:18356535,https://www.ncbi.nlm.nih.gov/pubmed/18356535,18356535,,
36,321699,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64241,ABCG8,https://ctdbase.org/detail.go?type=gene&acc=64241,,,64241.0,ABCG8,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of ABCG8 mrna|[abcg5 protein binds to ABCG8 protein] which affects the transport of cholesterol|cholesterol results in decreased expression of ABCG8 mRNA,,,PMID:15683829,https://www.ncbi.nlm.nih.gov/pubmed/15683829,15683829,,
37,321700,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64241,ABCG8,https://ctdbase.org/detail.go?type=gene&acc=64241,,,64241.0,ABCG8,10116.0,Rattus norvegicus (Norway rat),[diosgenin results in increased expression of ABCG8 mrna] which results in increased secretion of cholesterol|[ethinyl estradiol results in decreased expression of ABCG8 mrna] which results in decreased secretion of cholesterol,,,PMID:12963437,https://www.ncbi.nlm.nih.gov/pubmed/12963437,12963437,,
38,321701,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose co-treated with ethinyl estradiol] results in increased expression of ACACA mrna|[lard co-treated with cholesterol co-treated with sucrose co-treated with atrazine] results in increased expression of ACACA mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
39,321702,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,34,ACADM,https://ctdbase.org/detail.go?type=gene&acc=34,,,34.0,ACADM,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of ACADM mrna|atrazine promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of ACADM mrna],,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
40,321880,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10090.0,Mus musculus (house mouse),[copper co-treated with cholesterol] results in increased activity of ACHE protein|clioquinol inhibits the reaction [[copper co-treated with cholesterol] results in increased activity of ACHE protein],,,PMID:25856695,https://www.ncbi.nlm.nih.gov/pubmed/25856695,25856695,,
41,321881,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,47,ACLY,https://ctdbase.org/detail.go?type=gene&acc=47,,,47.0,ACLY,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose co-treated with atrazine] results in increased expression of ACLY mrna|[lard co-treated with cholesterol co-treated with sucrose co-treated with ethinyl estradiol] results in increased expression of ACLY mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
42,321882,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,51,ACOX1,https://ctdbase.org/detail.go?type=gene&acc=51,,,51.0,ACOX1,10090.0,Mus musculus (house mouse),Ethinyl estradiol promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of ACOX1 mrna]|[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of ACOX1 mrna|atrazine promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of ACOX1 mrna]|cypermethrin promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of ACOX1 mrna],,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
43,321883,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10090.0,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [[bisphenol A co-treated with dietary fats co-treated with cholesterol co-treated with cholic acid] results in increased expression of ACTA2 protein]|[bisphenol A co-treated with dietary fats co-treated with cholesterol co-treated with cholic acid] results in increased expression of ACTA2 protein,,,PMID:35622622,https://www.ncbi.nlm.nih.gov/pubmed/35622622,35622622,,
44,321884,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9370,ADIPOQ,https://ctdbase.org/detail.go?type=gene&acc=9370,,,9370.0,ADIPOQ,9986.0,Oryctolagus cuniculus (rabbit),Cholesterol results in decreased expression of ADIPOQ protein|niacin inhibits the reaction [cholesterol results in decreased expression of ADIPOQ protein],,,PMID:17611329,https://www.ncbi.nlm.nih.gov/pubmed/17611329,17611329,,
45,321885,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,177,AGER,https://ctdbase.org/detail.go?type=gene&acc=177,,,177.0,AGER,9606.0,Homo sapiens (human),AGER protein affects the abundance of cholesterol,,,PMID:20372816,https://www.ncbi.nlm.nih.gov/pubmed/20372816,20372816,,
46,321886,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [irbesartan results in increased expression of AGT protein]|cholesterol results in increased expression of AGT protein,,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
47,321887,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),Hydralazine inhibits the reaction [AGT protein affects the abundance of cholesterol]|agt protein affects the abundance of cholesterol|losartan inhibits the reaction [AGT protein affects the abundance of cholesterol],,,PMID:19109942,https://www.ncbi.nlm.nih.gov/pubmed/19109942,19109942,,
48,321888,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,183,AGT,https://ctdbase.org/detail.go?type=gene&acc=183,,,183.0,AGT,10116.0,Rattus norvegicus (Norway rat),[puromycin aminonucleoside co-treated with cholesterol] results in increased expression of AGT mRNA,,,PMID:12495295,https://www.ncbi.nlm.nih.gov/pubmed/12495295,12495295,,
49,322049,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,185,AGTR1,https://ctdbase.org/detail.go?type=gene&acc=185,,,185.0,AGTR1,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [irbesartan results in increased expression of AGTR1 mrna]|cholesterol results in increased expression of AGTR1 mRNA,,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
50,322050,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,186,AGTR2,https://ctdbase.org/detail.go?type=gene&acc=186,,,186.0,AGTR2,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with methylthiouracil] results in increased expression of AGTR2 mrna|rosiglitazone promotes the reaction [[cholesterol co-treated with methylthiouracil] results in increased expression of AGTR2 protein]|rosiglitazone promotes the reaction [[cholesterol co-treated with methylthiouracil] results in increased expression of AGTR2 mrna]|[cholesterol co-treated with methylthiouracil] results in increased expression of AGTR2 protein,,,PMID:21269478,https://www.ncbi.nlm.nih.gov/pubmed/21269478,21269478,,
51,322051,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,186,AGTR2,https://ctdbase.org/detail.go?type=gene&acc=186,,,186.0,AGTR2,10116.0,Rattus norvegicus (Norway rat),[puromycin aminonucleoside co-treated with cholesterol] results in increased expression of AGTR2 mRNA,,,PMID:12495295,https://www.ncbi.nlm.nih.gov/pubmed/12495295,12495295,,
52,322052,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),[beta-naphthoflavone results in increased activity of AHR protein] which results in decreased chemical synthesis of and results in decreased secretion of cholesterol,,,PMID:22234961,https://www.ncbi.nlm.nih.gov/pubmed/22234961,22234961,,
53,322053,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Cholesterol results in increased expression of and results in increased phosphorylation of AKT1 protein,,,PMID:19672739,https://www.ncbi.nlm.nih.gov/pubmed/19672739,19672739,,
54,322054,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [irbesartan results in increased expression of AKT1 protein],,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
55,322055,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),[streptozocin co-treated with coconut oil co-treated with cholesterol] results in decreased phosphorylation of AKT1 protein|metformin inhibits the reaction [[streptozocin co-treated with coconut oil co-treated with cholesterol] results in decreased phosphorylation of AKT1 protein]|plant extracts inhibits the reaction [[streptozocin co-treated with coconut oil co-treated with cholesterol] results in decreased phosphorylation of AKT1 protein],,,PMID:31877369,https://www.ncbi.nlm.nih.gov/pubmed/31877369,31877369,,
56,322056,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10116.0,Rattus norvegicus (Norway rat),[lard co-treated with cholesterol] results in increased expression of ALB protein|[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of ALB protein,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
57,322057,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,302,ANXA2,https://ctdbase.org/detail.go?type=gene&acc=302,,,302.0,ANXA2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of ANXA2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
58,322195,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,10116.0,Rattus norvegicus (Norway rat),"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased expression of APAF1 mrna]|cholesterol analog results in increased expression of APAF1 mrna|acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of APAF1 mrna]",,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
59,322196,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Arachidonic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|apoa1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]|pld2 protein affects the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of cholesterol]]|oleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|mastoparan inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of cholesterol]]|palmitoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|1-oleoyl-2-acetylglycerol inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|linoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased transport of cholesterol]]|pld2 protein inhibits the reaction [linoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of cholesterol]]],,,PMID:16118212,https://www.ncbi.nlm.nih.gov/pubmed/16118212,16118212,,
60,322197,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [APOA1 protein results in increased transport of cholesterol]|[pirinixic acid binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of cholesterol]|[bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of cholesterol]|apoa1 protein results in increased transport of cholesterol,,,PMID:12595494,https://www.ncbi.nlm.nih.gov/pubmed/12595494,12595494,,
61,322198,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),[acrolein affects the metabolism of APOA1 protein] which results in decreased secretion of cholesterol,,,PMID:16126721,https://www.ncbi.nlm.nih.gov/pubmed/16126721,16126721,,
62,322199,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Acrolein inhibits the reaction [APOA1 protein affects the transport of cholesterol],,,PMID:16037261,https://www.ncbi.nlm.nih.gov/pubmed/16037261,16037261,,
63,322200,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),APOA1 protein promotes the reaction [ABCA1 protein results in increased export of cholesterol],,,PMID:15983222,https://www.ncbi.nlm.nih.gov/pubmed/15983222,15983222,,
64,322201,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Resveratrol inhibits the reaction [APOA1 protein results in increased export of cholesterol]|apoa1 protein results in increased export of cholesterol,,,PMID:23041272,https://www.ncbi.nlm.nih.gov/pubmed/23041272,23041272,,
65,322202,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),APOA1 protein results in increased secretion of cholesterol,,,PMID:12531903|PMID:20056921,https://www.ncbi.nlm.nih.gov/pubmed/12531903|https://www.ncbi.nlm.nih.gov/pubmed/20056921,12531903|20056921,,
66,322353,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),CYP27A1 protein promotes the reaction [APOA1 protein results in increased secretion of cholesterol],,,PMID:12531903,https://www.ncbi.nlm.nih.gov/pubmed/12531903,12531903,,
67,322354,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Fingolimod hydrochloride promotes the reaction [APOA1 protein results in increased secretion of cholesterol],,,PMID:20056921,https://www.ncbi.nlm.nih.gov/pubmed/20056921,20056921,,
68,322355,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606.0,Homo sapiens (human),Isosilybin A promotes the reaction [APOA1 protein results in increased secretion of cholesterol],,,PMID:26729088,https://www.ncbi.nlm.nih.gov/pubmed/26729088,26729088,,
69,322356,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,10090.0,Mus musculus (house mouse),27-hydroxycholesterol promotes the reaction [STAR protein promotes the reaction [[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol]]|27-hydroxycholesterol promotes the reaction [[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol]|probucol inhibits the reaction [STAR protein promotes the reaction [[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol]]|probucol inhibits the reaction [[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol]|star protein promotes the reaction [[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol]|[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol|t0901317 promotes the reaction [[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol]|[t0901317 co-treated with APOA1 protein] results in increased secretion of cholesterol,,,PMID:20083572,https://www.ncbi.nlm.nih.gov/pubmed/20083572,20083572,,
70,322357,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,10090.0,Mus musculus (house mouse),2-chloro-5-nitrobenzanilide inhibits the reaction [niacin promotes the reaction [APOA1 protein results in increased export of cholesterol]]|pparg protein promotes the reaction [niacin promotes the reaction [APOA1 protein results in increased export of cholesterol]]|niacin promotes the reaction [APOA1 protein results in increased export of cholesterol],,,PMID:19797938,https://www.ncbi.nlm.nih.gov/pubmed/19797938,19797938,,
71,322358,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,10090.0,Mus musculus (house mouse),Aspirin promotes the reaction [APOA1 affects the transport of cholesterol]|apoa1 affects the transport of cholesterol|ppara affects the reaction [aspirin promotes the reaction [APOA1 affects the transport of cholesterol]],,,PMID:21088444,https://www.ncbi.nlm.nih.gov/pubmed/21088444,21088444,,
72,322359,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,10090.0,Mus musculus (house mouse),APOA1 protein results in increased export of cholesterol,,,PMID:19797938|PMID:25204422,https://www.ncbi.nlm.nih.gov/pubmed/19797938|https://www.ncbi.nlm.nih.gov/pubmed/25204422,19797938|25204422,,
73,322360,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,10090.0,Mus musculus (house mouse),Cholesterol results in decreased expression of APOA1 protein,,,PMID:16115471,https://www.ncbi.nlm.nih.gov/pubmed/16115471,16115471,,
74,322361,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,10090.0,Mus musculus (house mouse),[glutathione co-treated with quercetin] promotes the reaction [APOA1 protein results in increased export of cholesterol]|quercetin promotes the reaction [APOA1 protein results in increased export of cholesterol],,,PMID:25204422,https://www.ncbi.nlm.nih.gov/pubmed/25204422,25204422,,
75,322523,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,10116.0,Rattus norvegicus (Norway rat),[ethanol co-treated with APOA1 protein] results in decreased abundance of cholesterol,,,PMID:17478430,https://www.ncbi.nlm.nih.gov/pubmed/17478430,17478430,,
76,322524,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9823.0,Sus scrofa (pig),Troglitazone promotes the reaction [APOA1 protein results in increased transport of cholesterol]|pioglitazone promotes the reaction [APOA1 protein results in increased transport of cholesterol]|fenofibrate inhibits the reaction [APOA1 protein results in increased transport of cholesterol]|apoa1 protein results in increased transport of cholesterol|24-hydroxycholesterol promotes the reaction [APOA1 protein results in increased transport of cholesterol]|fenofibrate promotes the reaction [APOA1 protein results in increased transport of cholesterol]|t0901317 promotes the reaction [APOA1 protein results in increased transport of cholesterol],,,PMID:16530456,https://www.ncbi.nlm.nih.gov/pubmed/16530456,16530456,,
77,322525,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,10116.0,Rattus norvegicus (Norway rat),Cholesterol results in increased expression of APOB protein,,,PMID:16271152|PMID:16581047,https://www.ncbi.nlm.nih.gov/pubmed/16271152|https://www.ncbi.nlm.nih.gov/pubmed/16581047,16271152|16581047,,
78,322526,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,338,APOB,https://ctdbase.org/detail.go?type=gene&acc=338,,,338.0,APOB,10116.0,Rattus norvegicus (Norway rat),Selenium inhibits the reaction [cholesterol results in increased expression of APOB protein],,,PMID:16581047,https://www.ncbi.nlm.nih.gov/pubmed/16581047,16581047,,
79,322527,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),T0901317 promotes the reaction [[APOE gene mutant form results in increased susceptibility to dietary fats] which results in increased abundance of cholesterol]|24-diamino-5-phenylthiazole inhibits the reaction [T0901317 promotes the reaction [[APOE gene mutant form results in increased susceptibility to dietary fats] which results in increased abundance of cholesterol]],,,PMID:32853627,https://www.ncbi.nlm.nih.gov/pubmed/32853627,32853627,,
80,322528,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),[[air pollutants results in increased abundance of particulate matter] promotes the reaction [APOE protein affects the susceptibility to dietary fats]] which affects the abundance of cholesterol|n-butyloxycarbonyl-methionyl-aspartyl-glycyl-cysteinyl-glutamyl-leucine inhibits the reaction [[[air pollutants results in increased abundance of particulate matter] promotes the reaction [APOE protein affects the susceptibility to dietary fats]] which affects the abundance of cholesterol],,,PMID:34673409,https://www.ncbi.nlm.nih.gov/pubmed/34673409,34673409,,
81,322529,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),Capsaicin inhibits the reaction [[APOE affects the susceptibility to dietary fats] which affects the abundance of cholesterol]|[apoe affects the susceptibility to dietary fats] which affects the abundance of cholesterol,,,PMID:21908651,https://www.ncbi.nlm.nih.gov/pubmed/21908651,21908651,,
82,322530,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),APOE gene mutant form promotes the reaction [dietary fats results in increased abundance of cholesterol],,,PMID:11397713,https://www.ncbi.nlm.nih.gov/pubmed/11397713,11397713,,
83,322687,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),APOE gene mutant form results in increased abundance of cholesterol,,,PMID:24933211|PMID:25037058,https://www.ncbi.nlm.nih.gov/pubmed/24933211|https://www.ncbi.nlm.nih.gov/pubmed/25037058,24933211|25037058,,
84,322688,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),"APOE inhibits the reaction [cholesterol, dietary results in increased abundance of cholesterol]",,,PMID:12472773,https://www.ncbi.nlm.nih.gov/pubmed/12472773,12472773,,
85,322689,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),APOE protein affects the susceptibility to cholesterol,,,PMID:16179587,https://www.ncbi.nlm.nih.gov/pubmed/16179587,16179587,,
86,322690,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),APOE protein results in increased export of cholesterol,,,PMID:22022523,https://www.ncbi.nlm.nih.gov/pubmed/22022523,22022523,,
87,322691,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),CAV1 protein affects the reaction [cholesterol affects the localization of APOE protein]|cholesterol affects the localization of APOE protein|cholesterol promotes the reaction [APOE protein binds to CAV1 protein]|methyl-beta-cyclodextrin inhibits the reaction [cholesterol affects the localization of APOE protein],,,PMID:21169230,https://www.ncbi.nlm.nih.gov/pubmed/21169230,21169230,,
88,322692,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),Enalapril inhibits the reaction [APOE gene mutant form results in increased abundance of cholesterol]|paricalcitol inhibits the reaction [APOE gene mutant form results in increased abundance of cholesterol],,,PMID:25037058,https://www.ncbi.nlm.nih.gov/pubmed/25037058,25037058,,
89,322693,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,348,APOE,https://ctdbase.org/detail.go?type=gene&acc=348,,,348.0,APOE,10090.0,Mus musculus (house mouse),Notoginsenoside R1 inhibits the reaction [APOE gene mutant form results in increased abundance of cholesterol],,,PMID:24933211,https://www.ncbi.nlm.nih.gov/pubmed/24933211,24933211,,
90,322694,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,108956,APOL7C,https://ctdbase.org/detail.go?type=gene&acc=108956,,,108956.0,Apol7c,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of APOL7C mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
91,322695,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10090.0,Mus musculus (house mouse),[copper co-treated with cholesterol] results in increased expression of APP mRNA,,,PMID:17134702,https://www.ncbi.nlm.nih.gov/pubmed/17134702,17134702,,
92,322696,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9986.0,Oryctolagus cuniculus (rabbit),Cholesterol results in increased expression of APP protein,,,PMID:12515903,https://www.ncbi.nlm.nih.gov/pubmed/12515903,12515903,,
93,322835,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116.0,Rattus norvegicus (Norway rat),APP protein results in increased oxidation of cholesterol,,,PMID:15591071,https://www.ncbi.nlm.nih.gov/pubmed/15591071,15591071,,
94,322836,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606.0,Homo sapiens (human),Cholesterol affects the folding of and affects the localization of APP protein,,,PMID:16689927,https://www.ncbi.nlm.nih.gov/pubmed/16689927,16689927,,
95,322837,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606.0,Homo sapiens (human),Cholesterol affects the reaction [[APP protein modified form binds to copper] which results in increased chemical synthesis of hydrogen peroxide],,,PMID:12192006,https://www.ncbi.nlm.nih.gov/pubmed/12192006,12192006,,
96,322838,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,9606.0,Homo sapiens (human),Cholesterol results in increased expression of APP protein,,,PMID:16828233,https://www.ncbi.nlm.nih.gov/pubmed/16828233,16828233,,
97,322839,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,366,AQP9,https://ctdbase.org/detail.go?type=gene&acc=366,,,366.0,AQP9,9606.0,Homo sapiens (human),Cholesterol results in increased expression of AQP9 mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
98,322840,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,374,AREG,https://ctdbase.org/detail.go?type=gene&acc=374,,,374.0,AREG,9606.0,Homo sapiens (human),CLEC4E protein promotes the reaction [cholesterol results in increased expression of AREG mrna]|cholesterol results in increased expression of AREG mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
99,322841,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,540,ATP7B,https://ctdbase.org/detail.go?type=gene&acc=540,,,540.0,ATP7B,10116.0,Rattus norvegicus (Norway rat),ATP7B gene mutant form results in increased abundance of cholesterol,,,PMID:17303181,https://www.ncbi.nlm.nih.gov/pubmed/17303181,17303181,,
100,322842,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [cadmium chloride results in increased expression of BAX protein],,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
101,322843,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in decreased expression of BAX mRNA,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
102,322844,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [cadmium chloride results in decreased expression of BCL2 protein],,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
103,322845,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in decreased expression of BCL2 mRNA,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
104,322985,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,597,BCL2A1,https://ctdbase.org/detail.go?type=gene&acc=597,,,597.0,BCL2A1,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in increased expression of BCL2A1 mRNA,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
105,322986,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [arachidonyl dopamine results in decreased expression of BCL2L1 mrna],,,PMID:33393692,https://www.ncbi.nlm.nih.gov/pubmed/33393692,33393692,,
106,322987,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116.0,Rattus norvegicus (Norway rat),Selenium inhibits the reaction [[dietary fats co-treated with cholesterol] results in decreased expression of BDNF protein]|[dietary fats co-treated with cholesterol] results in decreased expression of BDNF protein,,,PMID:30695686,https://www.ncbi.nlm.nih.gov/pubmed/30695686,30695686,,
107,322988,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,638,BIK,https://ctdbase.org/detail.go?type=gene&acc=638,,,638.0,BIK,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in increased expression of BIK mRNA,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
108,322989,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,179542,C06H2.2,https://ctdbase.org/detail.go?type=gene&acc=179542,,,179542.0,C06H2.2,6239.0,Caenorhabditis elegans,Cholesterol inhibits the reaction [bisphenol A results in increased expression of C06H2.2 mrna],,,PMID:31445225,https://www.ncbi.nlm.nih.gov/pubmed/31445225,31445225,,
109,322990,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,84419,C15ORF48,https://ctdbase.org/detail.go?type=gene&acc=84419,,,84419.0,C15orf48,9606.0,Homo sapiens (human),Cholesterol results in increased expression of C15ORF48 mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
110,322991,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10090.0,Mus musculus (house mouse),Methyl-beta-cyclodextrin inhibits the reaction [cholesterol analog results in increased activity of CASP1 protein]|amitriptyline inhibits the reaction [cholesterol analog results in increased activity of CASP1 protein]|smpd1 protein affects the reaction [cholesterol analog affects the localization of CASP1 protein]|cholesterol analog affects the localization of CASP1 protein|smpd1 protein affects the reaction [cholesterol analog results in increased activity of CASP1 protein]|tempol inhibits the reaction [cholesterol analog results in increased activity of CASP1 protein]|amitriptyline inhibits the reaction [cholesterol analog affects the localization of CASP1 protein]|cholesterol analog results in increased activity of CASP1 protein|verapamil inhibits the reaction [cholesterol analog results in increased activity of CASP1 protein],,,PMID:28633109,https://www.ncbi.nlm.nih.gov/pubmed/28633109,28633109,,
111,322992,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in increased expression of CASP1 mRNA,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
112,322993,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of CASP1 protein]|[cholesterol co-treated with ergosterol] results in increased expression of CASP1 protein|[cholesterol co-treated with ergosterol] results in increased expression of CASP1 mrna|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of CASP1 mrna],,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
113,323153,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Cholesterol results in increased cleavage of CASP3 protein,,,PMID:28275691,https://www.ncbi.nlm.nih.gov/pubmed/28275691,28275691,,
114,323154,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9913.0,Bos taurus (cattle),Cholesterol inhibits the reaction [methoxychlor results in decreased activity of CYP11A1 protein],,,PMID:8431464,https://www.ncbi.nlm.nih.gov/pubmed/8431464,8431464,,
115,323155,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606.0,Homo sapiens (human),CYP11A1 protein affects the metabolism of cholesterol,,,PMID:16054388,https://www.ncbi.nlm.nih.gov/pubmed/16054388,16054388,,
116,323156,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),"[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] promotes the reaction [silver compounds results in increased activity of CASP3 protein]|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in increased activity of CASP3 protein|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] inhibits the reaction [silver compounds results in increased activity of CASP3 protein]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] results in decreased activity of CASP3 protein",,,PMID:35385781,https://www.ncbi.nlm.nih.gov/pubmed/35385781,35385781,,
117,323157,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),[bisphenol A co-treated with dietary fats co-treated with cholesterol co-treated with cholic acid] results in increased cleavage of CASP3 protein|acetylcysteine inhibits the reaction [[bisphenol A co-treated with dietary fats co-treated with cholesterol co-treated with cholic acid] results in increased cleavage of CASP3 protein],,,PMID:35622622,https://www.ncbi.nlm.nih.gov/pubmed/35622622,35622622,,
118,323158,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [cadmium chloride results in increased expression of CASP3 protein modified form],,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
119,323159,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),Methyl-beta-cyclodextrin inhibits the reaction [cholesterol results in increased activity of CASP3 protein]|cholesterol results in increased activity of CASP3 protein,,,PMID:21872649,https://www.ncbi.nlm.nih.gov/pubmed/21872649,21872649,,
120,323160,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10090.0,Mus musculus (house mouse),[copper co-treated with cholesterol] results in increased activity of CASP3 protein,,,PMID:17134702,https://www.ncbi.nlm.nih.gov/pubmed/17134702,17134702,,
121,323342,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),"Cholesterol analog results in increased expression of CASP3 mrna|cholesterol analog results in increased cleavage of CASP3 protein|acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of CASP3 mrna]|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased expression of CASP3 mrna]",,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
122,323343,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,837,CASP4,https://ctdbase.org/detail.go?type=gene&acc=837,,,837.0,CASP4,10116.0,Rattus norvegicus (Norway rat),"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased expression of CASP4 mrna]|acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of CASP4 mrna]|cholesterol analog results in increased expression of CASP4 mRNA",,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
123,323344,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10116.0,Rattus norvegicus (Norway rat),"Acetylcysteine inhibits the reaction [cholesterol analog results in increased activity of CASP8 protein]|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased activity of CASP8 protein]|cholesterol analog results in increased activity of CASP8 protein|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased expression of CASP8 mrna]|cholesterol analog results in increased expression of CASP8 mrna|acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of CASP8 mrna]",,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
124,323345,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841.0,CASP8,10116.0,Rattus norvegicus (Norway rat),Cholesterol promotes the reaction [hydrogen peroxide results in increased expression of CASP8 protein]|cholesterol results in increased expression of CASP8 protein|hydrogen peroxide promotes the reaction [cholesterol results in increased expression of CASP8 protein],,,PMID:20946910,https://www.ncbi.nlm.nih.gov/pubmed/20946910,20946910,,
125,323346,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),"[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] promotes the reaction [silver compounds results in increased activity of CASP9 protein]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds results in increased activity of CASP9 protein]|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in increased activity of CASP9 protein",,,PMID:35385781,https://www.ncbi.nlm.nih.gov/pubmed/35385781,35385781,,
126,323347,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116.0,Rattus norvegicus (Norway rat),"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased expression of CASP9 mrna]|acetylcysteine inhibits the reaction [cholesterol analog results in increased activity of CASP9 protein]|cholesterol analog results in increased expression of CASP9 mrna|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased activity of CASP9 protein]|acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of CASP9 mrna]|cholesterol analog results in increased activity of CASP9 protein",,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
127,323348,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606.0,Homo sapiens (human),"[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the expression of CAT mrna|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds affects the expression of CAT mrna]|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in decreased activity of CAT protein|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds results in decreased activity of CAT protein]|[egf protein co-treated with [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]]] inhibits the reaction [[EGF protein co-treated with silver compounds] results in increased activity of CAT protein]|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in decreased expression of CAT mRNA",,,PMID:35385781,https://www.ncbi.nlm.nih.gov/pubmed/35385781,35385781,,
128,323499,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of CAT protein,,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
129,323500,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Lupeol linoleate inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased activity of CAT protein]|lupeol inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased activity of CAT protein]|[cholesterol co-treated with cholic acid] results in decreased activity of CAT protein,,,PMID:16933029,https://www.ncbi.nlm.nih.gov/pubmed/16933029,16933029,,
130,323501,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,857,CAV1,https://ctdbase.org/detail.go?type=gene&acc=857,,,857.0,CAV1,9606.0,Homo sapiens (human),CAV1 protein results in increased transport of cholesterol,,,PMID:12640124,https://www.ncbi.nlm.nih.gov/pubmed/12640124,12640124,,
131,323502,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,857,CAV1,https://ctdbase.org/detail.go?type=gene&acc=857,,,857.0,CAV1,10090.0,Mus musculus (house mouse),CAV1 protein affects the reaction [cholesterol affects the localization of APOE protein]|cholesterol promotes the reaction [APOE protein binds to CAV1 protein],,,PMID:21169230,https://www.ncbi.nlm.nih.gov/pubmed/21169230,21169230,,
132,323503,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,859,CAV3,https://ctdbase.org/detail.go?type=gene&acc=859,,,859.0,CAV3,9606.0,Homo sapiens (human),CAV3 protein affects the import of cholesterol,,,PMID:19221014,https://www.ncbi.nlm.nih.gov/pubmed/19221014,19221014,,
133,323504,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6346,CCL1,https://ctdbase.org/detail.go?type=gene&acc=6346,,,6346.0,CCL1,9606.0,Homo sapiens (human),Cholesterol results in increased expression of CCL1 mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
134,323505,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9541.0,Macaca fascicularis (crab-eating macaque),Olmesartan inhibits the reaction [cholesterol results in increased expression of CCL2 protein]|cholesterol results in increased expression of CCL2 protein,,,PMID:16148612,https://www.ncbi.nlm.nih.gov/pubmed/16148612,16148612,,
135,323506,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CCL2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
136,323507,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [irbesartan results in increased expression of CCL2 protein]|cholesterol inhibits the reaction [irbesartan results in increased expression of CCL2 mrna]|cholesterol results in increased expression of CCL2 protein|cholesterol results in increased expression of CCL2 mRNA,,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
137,323508,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of CCL2 protein]|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of CCL2 mrna]|[cholesterol co-treated with ergosterol] results in increased expression of CCL2 protein|[cholesterol co-treated with ergosterol] results in increased expression of CCL2 mRNA,,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
138,323651,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of CCL2 mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
139,323652,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6351,CCL4,https://ctdbase.org/detail.go?type=gene&acc=6351,,,6351.0,CCL4,9606.0,Homo sapiens (human),Cholesterol results in increased expression of CCL4 mrna|clec4e protein promotes the reaction [cholesterol results in increased expression of CCL4 mrna],,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
140,323653,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6354,CCL7,https://ctdbase.org/detail.go?type=gene&acc=6354,,,6354.0,CCL7,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CCL7 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
141,323654,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10090.0,Mus musculus (house mouse),[bisphenol A co-treated with dietary fats co-treated with cholesterol co-treated with cholic acid] results in increased expression of CD36 protein|acetylcysteine inhibits the reaction [[bisphenol A co-treated with dietary fats co-treated with cholesterol co-treated with cholic acid] results in increased expression of CD36 protein],,,PMID:35622622,https://www.ncbi.nlm.nih.gov/pubmed/35622622,35622622,,
142,323655,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,10090.0,Mus musculus (house mouse),Rosiglitazone inhibits the reaction [[dietary fats co-treated with cholesterol] results in increased expression of CD36 mrna]|[dietary fats co-treated with cholesterol] results in increased expression of CD36 mrna|losartan promotes the reaction [[dietary fats co-treated with cholesterol] results in increased expression of CD36 mrna],,,PMID:18302760,https://www.ncbi.nlm.nih.gov/pubmed/18302760,18302760,,
143,323656,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,948,CD36,https://ctdbase.org/detail.go?type=gene&acc=948,,,948.0,CD36,9986.0,Oryctolagus cuniculus (rabbit),Niacin inhibits the reaction [cholesterol results in decreased expression of CD36 mrna]|cholesterol results in decreased expression of CD36 mRNA,,,PMID:18402819,https://www.ncbi.nlm.nih.gov/pubmed/18402819,18402819,,
144,323657,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,959,CD40LG,https://ctdbase.org/detail.go?type=gene&acc=959,,,959.0,CD40LG,10116.0,Rattus norvegicus (Norway rat),"Acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of CD40LG mrna]|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased expression of CD40LG mrna]|cholesterol analog results in increased expression of CD40LG mRNA",,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
145,323658,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [arachidonyl dopamine results in decreased expression of CDK4 mrna],,,PMID:33393692,https://www.ncbi.nlm.nih.gov/pubmed/33393692,33393692,,
146,323659,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8941,CDK5R2,https://ctdbase.org/detail.go?type=gene&acc=8941,,,8941.0,CDK5R2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CDK5R2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
147,323823,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CDKN1A mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
148,323824,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1050,CEBPA,https://ctdbase.org/detail.go?type=gene&acc=1050,,,1050.0,CEBPA,9606.0,Homo sapiens (human),[[artemisic acid results in decreased expression of CEBPA mrna] which results in decreased expression of HMGCR mrna] which results in decreased chemical synthesis of cholesterol,,,PMID:23063590,https://www.ncbi.nlm.nih.gov/pubmed/23063590,23063590,,
149,323825,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1066,CES1,https://ctdbase.org/detail.go?type=gene&acc=1066,,,1066.0,CES1,9606.0,Homo sapiens (human),CES1 protein results in increased metabolism of cholesterol,,,PMID:11015575|PMID:12773168|PMID:8049197,https://www.ncbi.nlm.nih.gov/pubmed/11015575|https://www.ncbi.nlm.nih.gov/pubmed/12773168|https://www.ncbi.nlm.nih.gov/pubmed/8049197,11015575|12773168|8049197,,
150,323826,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1066,CES1,https://ctdbase.org/detail.go?type=gene&acc=1066,,,1066.0,CES1,9606.0,Homo sapiens (human),Cholesterol results in increased expression of CES1 mRNA,,,PMID:8049197,https://www.ncbi.nlm.nih.gov/pubmed/8049197,8049197,,
151,323827,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1066,CES1,https://ctdbase.org/detail.go?type=gene&acc=1066,,,1066.0,CES1,10116.0,Rattus norvegicus (Norway rat),CES1 protein results in increased abundance of cholesterol,,,PMID:15825828,https://www.ncbi.nlm.nih.gov/pubmed/15825828,15825828,,
152,323828,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1071,CETP,https://ctdbase.org/detail.go?type=gene&acc=1071,,,1071.0,CETP,9606.0,Homo sapiens (human),Teniposide promotes the reaction [CETP protein results in decreased abundance of cholesterol],,,PMID:25914138,https://www.ncbi.nlm.nih.gov/pubmed/25914138,25914138,,
153,323829,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1071,CETP,https://ctdbase.org/detail.go?type=gene&acc=1071,,,1071.0,CETP,9986.0,Oryctolagus cuniculus (rabbit),[cholesterol co-treated with probucol co-treated with bezafibrate] results in increased activity of CETP protein|cholesterol results in increased activity of CETP protein|[cholesterol co-treated with probucol] results in increased activity of CETP protein|bezafibrate inhibits the reaction [cholesterol results in increased activity of CETP protein],,,PMID:10406588,https://www.ncbi.nlm.nih.gov/pubmed/10406588,10406588,,
154,323830,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,12655,CHIL3,https://ctdbase.org/detail.go?type=gene&acc=12655,,,12655.0,Chil3,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CHIL3 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
155,323831,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,26253,CLEC4E,https://ctdbase.org/detail.go?type=gene&acc=26253,,,26253.0,CLEC4E,9606.0,Homo sapiens (human),CLEC4E protein promotes the reaction [[cholesterol co-treated with lipopolysaccharides] results in increased expression of IL1B protein]|clec4e protein promotes the reaction [cholesterol results in increased expression of CLEC5A mrna]|[cholesterol co-treated with CLEC4E] results in increased expression of TNF protein|cholesterol binds to and results in increased activity of CLEC4E protein|clec4e protein promotes the reaction [cholesterol results in increased expression of AREG mrna]|clec4e protein promotes the reaction [cholesterol results in increased expression of CCL4 mrna]|clec4e protein promotes the reaction [cholesterol results in increased expression of CSF1 mrna]|clec4e protein results in increased susceptibility to cholesterol|[cholesterol co-treated with CLEC4E] results in increased expression of CXCL2 protein|clec4e protein inhibits the reaction [cholesterol results in increased expression of TIMP3 mrna]|clec4e protein promotes the reaction [cholesterol results in increased expression of DCSTAMP mrna],,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
156,323970,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,23601,CLEC5A,https://ctdbase.org/detail.go?type=gene&acc=23601,,,23601.0,CLEC5A,9606.0,Homo sapiens (human),CLEC4E protein promotes the reaction [cholesterol results in increased expression of CLEC5A mrna]|cholesterol results in increased expression of CLEC5A mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
157,323971,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,10090.0,Mus musculus (house mouse),Cypermethrin promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of CPT1A mrna]|[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of CPT1A mrna|atrazine promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of CPT1A mrna]|ethinyl estradiol promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of CPT1A mrna],,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
158,323972,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10116.0,Rattus norvegicus (Norway rat),[dietary fats co-treated with cholesterol] results in decreased expression of CREB1 protein|selenium inhibits the reaction [[dietary fats co-treated with cholesterol] results in decreased expression of CREB1 protein],,,PMID:30695686,https://www.ncbi.nlm.nih.gov/pubmed/30695686,30695686,,
159,323973,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1417,CRYBB3,https://ctdbase.org/detail.go?type=gene&acc=1417,,,1417.0,CRYBB3,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CRYBB3 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
160,323974,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1431,CS,https://ctdbase.org/detail.go?type=gene&acc=1431,,,1431.0,CS,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of CS mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
161,323975,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1435,CSF1,https://ctdbase.org/detail.go?type=gene&acc=1435,,,1435.0,CSF1,9606.0,Homo sapiens (human),Cholesterol results in increased expression of CSF1 mrna|clec4e protein promotes the reaction [cholesterol results in increased expression of CSF1 mrna],,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
162,323976,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1471,CST3,https://ctdbase.org/detail.go?type=gene&acc=1471,,,1471.0,CST3,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of CST3 protein,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
163,323977,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1508,CTSB,https://ctdbase.org/detail.go?type=gene&acc=1508,,,1508.0,CTSB,9606.0,Homo sapiens (human),Cholesterol results in decreased activity of CTSB protein,,,PMID:28275691,https://www.ncbi.nlm.nih.gov/pubmed/28275691,28275691,,
164,323978,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,9606.0,Homo sapiens (human),[cholesterol co-treated with CLEC4E] results in increased expression of CXCL2 protein,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
165,324140,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),[methyl-beta-cyclodextrin results in decreased abundance of cholesterol] inhibits the reaction [polystyrenes inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]],,,PMID:23274767,https://www.ncbi.nlm.nih.gov/pubmed/23274767,23274767,,
166,324141,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4283,CXCL9,https://ctdbase.org/detail.go?type=gene&acc=4283,,,4283.0,CXCL9,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of CXCL9 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
167,324142,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10090.0,Mus musculus (house mouse),Cholesterol analog affects the localization of CYBB protein,,,PMID:28633109,https://www.ncbi.nlm.nih.gov/pubmed/28633109,28633109,,
168,324143,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with particulate matter] results in increased expression of CYBB protein|alpha-linolenic acid inhibits the reaction [[cholesterol co-treated with particulate matter] results in increased expression of CYBB protein],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
169,324144,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1536,CYBB,https://ctdbase.org/detail.go?type=gene&acc=1536,,,1536.0,CYBB,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of CYBB mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
170,324145,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606.0,Homo sapiens (human),CYP11A1 protein results in increased metabolism of cholesterol,,,PMID:19900470,https://www.ncbi.nlm.nih.gov/pubmed/19900470,19900470,,
171,324146,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606.0,Homo sapiens (human),CYP11A1 protein affects the metabolism of cholesterol,,,PMID:10888668|PMID:16199348,https://www.ncbi.nlm.nih.gov/pubmed/10888668|https://www.ncbi.nlm.nih.gov/pubmed/16199348,10888668|16199348,,
172,324147,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606.0,Homo sapiens (human),CYP11A1 protein results in increased metabolism of cholesterol,,,PMID:11226075,https://www.ncbi.nlm.nih.gov/pubmed/11226075,11226075,,
173,324148,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1583,CYP11A1,https://ctdbase.org/detail.go?type=gene&acc=1583,,,1583.0,CYP11A1,9606.0,Homo sapiens (human),[CYP11A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of pregnenolone,,,PMID:11502818,https://www.ncbi.nlm.nih.gov/pubmed/11502818,11502818,,
174,324149,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,10090.0,Mus musculus (house mouse),CYP17A1 protein affects the chemical synthesis of cholesterol,,,PMID:15761033,https://www.ncbi.nlm.nih.gov/pubmed/15761033,15761033,,
175,324310,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),Cholesterol results in decreased activity of CYP1A1 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
176,324311,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),CYP27A1 protein promotes the reaction [APOA1 protein results in increased secretion of cholesterol]|cyp27a1 protein results in decreased chemical synthesis of cholesterol,,,PMID:12531903,https://www.ncbi.nlm.nih.gov/pubmed/12531903,12531903,,
177,324312,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased chemical synthesis of bile acids and salts] promotes the reaction [LDLR protein results in increased uptake of cholesterol],,,PMID:16477808,https://www.ncbi.nlm.nih.gov/pubmed/16477808,16477808,,
178,324313,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),CYP27A1 protein results in increased hydroxylation of and results in decreased abundance of cholesterol,,,PMID:11714861,https://www.ncbi.nlm.nih.gov/pubmed/11714861,11714861,,
179,324314,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased hydroxylation of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol,,,PMID:9660774,https://www.ncbi.nlm.nih.gov/pubmed/9660774,9660774,,
180,324315,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 25-hydroxycholesterol,,,PMID:8078928,https://www.ncbi.nlm.nih.gov/pubmed/8078928,8078928,,
181,324316,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol,,,PMID:11408283|PMID:9215552,https://www.ncbi.nlm.nih.gov/pubmed/11408283|https://www.ncbi.nlm.nih.gov/pubmed/9215552,11408283|9215552,,
182,324317,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol] which results in increased activity of HMGCR protein,,,PMID:11408283,https://www.ncbi.nlm.nih.gov/pubmed/11408283,11408283,,
183,324318,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 3-hydroxy-5-cholestenoic acid,,,PMID:8078928|PMID:9215552,https://www.ncbi.nlm.nih.gov/pubmed/8078928|https://www.ncbi.nlm.nih.gov/pubmed/9215552,8078928|9215552,,
184,324319,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),CYP27A1 protein results in increased secretion of cholesterol,,,PMID:12117727,https://www.ncbi.nlm.nih.gov/pubmed/12117727,12117727,,
185,324484,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,10090.0,Mus musculus (house mouse),[cholesterol deficiency co-treated with dietary fats] results in decreased expression of CYP27A1 mRNA,,,PMID:18356535,https://www.ncbi.nlm.nih.gov/pubmed/18356535,18356535,,
186,324485,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,10116.0,Rattus norvegicus (Norway rat),[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol,,,PMID:8496670,https://www.ncbi.nlm.nih.gov/pubmed/8496670,8496670,,
187,324486,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9822.0,Sus,[CYP27A1 protein results in increased hydroxylation of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol|[cyp27a1 protein results in increased hydroxylation of cholesterol] which results in increased chemical synthesis of 25-hydroxycholesterol|[cyp27a1 protein results in increased hydroxylation of cholesterol] which results in increased chemical synthesis of 24-hydroxycholesterol,,,PMID:8443234,https://www.ncbi.nlm.nih.gov/pubmed/8443234,8443234,,
188,324487,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol,,,PMID:19158428,https://www.ncbi.nlm.nih.gov/pubmed/19158428,19158428,,
189,324488,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of bile acids and salts,,,PMID:18817892,https://www.ncbi.nlm.nih.gov/pubmed/18817892,18817892,,
190,324489,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),CYP27A1 protein results in increased oxidation of cholesterol,,,PMID:15148325,https://www.ncbi.nlm.nih.gov/pubmed/15148325,15148325,,
191,324490,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1593,CYP27A1,https://ctdbase.org/detail.go?type=gene&acc=1593,,,1593.0,CYP27A1,9606.0,Homo sapiens (human),[CYP27A1 protein results in increased oxidation of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol,,,PMID:11514559,https://www.ncbi.nlm.nih.gov/pubmed/11514559,11514559,,
192,324491,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,13086,CYP2A4,https://ctdbase.org/detail.go?type=gene&acc=13086,,,13086.0,Cyp2a4,10090.0,Mus musculus (house mouse),Cholesterol results in decreased activity of CYP2A4 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
193,324492,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,13088,CYP2B10,https://ctdbase.org/detail.go?type=gene&acc=13088,,,13088.0,Cyp2b10,10090.0,Mus musculus (house mouse),Cholesterol results in decreased activity of CYP2B10 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
194,324493,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,10090.0,Mus musculus (house mouse),Cholesterol results in decreased activity of CYP2C9 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
195,324641,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10090.0,Mus musculus (house mouse),Cholesterol results in decreased activity of CYP2E1 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
196,324642,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682.0,Cyp3a2,10116.0,Rattus norvegicus (Norway rat),[CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in decreased abundance of cholesterol,,,PMID:34461081,https://www.ncbi.nlm.nih.gov/pubmed/34461081,34461081,,
197,324643,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642.0,Cyp3a23-3a1,10116.0,Rattus norvegicus (Norway rat),[CYP3A23-3A1 gene mutant form co-treated with CYP3A2 gene mutant form] results in decreased abundance of cholesterol,,,PMID:34461081,https://www.ncbi.nlm.nih.gov/pubmed/34461081,34461081,,
198,324644,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Cholesterol promotes the reaction [CYP3A4 protein results in increased oxidation of 7-benzyloxy-4-trifluoromethylcoumarin],,,PMID:19299527,https://www.ncbi.nlm.nih.gov/pubmed/19299527,19299527,,
199,324645,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),"[CYP3A4 protein results in increased oxidation of cholesterol] which results in increased chemical synthesis of cholest-5-ene-3,4-diol",,,PMID:11514559,https://www.ncbi.nlm.nih.gov/pubmed/11514559,11514559,,
200,324646,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,10090.0,Mus musculus (house mouse),Cholesterol results in decreased activity of CYP3A4 protein,,,PMID:18420780,https://www.ncbi.nlm.nih.gov/pubmed/18420780,18420780,,
201,324647,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10858,CYP46A1,https://ctdbase.org/detail.go?type=gene&acc=10858,,,10858.0,CYP46A1,9606.0,Homo sapiens (human),CYP46A1 gene SNP affects the metabolism of and affects the abundance of cholesterol,,,PMID:19286353,https://www.ncbi.nlm.nih.gov/pubmed/19286353,19286353,,
202,324648,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10858,CYP46A1,https://ctdbase.org/detail.go?type=gene&acc=10858,,,10858.0,CYP46A1,9606.0,Homo sapiens (human),CYP46A1 protein results in increased hydroxylation of cholesterol,,,PMID:14640697,https://www.ncbi.nlm.nih.gov/pubmed/14640697,14640697,,
203,324649,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10858,CYP46A1,https://ctdbase.org/detail.go?type=gene&acc=10858,,,10858.0,CYP46A1,9606.0,Homo sapiens (human),[CYP46A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 24-hydroxycholesterol,,,PMID:17532301,https://www.ncbi.nlm.nih.gov/pubmed/17532301,17532301,,
204,324650,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10858,CYP46A1,https://ctdbase.org/detail.go?type=gene&acc=10858,,,10858.0,CYP46A1,9606.0,Homo sapiens (human),CYP46A1 protein results in increased oxidation of cholesterol,,,PMID:15148325,https://www.ncbi.nlm.nih.gov/pubmed/15148325,15148325,,
205,324787,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10858,CYP46A1,https://ctdbase.org/detail.go?type=gene&acc=10858,,,10858.0,CYP46A1,9606.0,Homo sapiens (human),[CYP46A1 protein results in increased oxidation of cholesterol] which results in increased chemical synthesis of 24-hydroxycholesterol,,,PMID:11514559,https://www.ncbi.nlm.nih.gov/pubmed/11514559,11514559,,
206,324788,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,9606.0,Homo sapiens (human),CYP7A1 mRNA inhibits the reaction [cholesterol results in increased phosphorylation of EIF4EBP1 protein]|cyp7a1 mRNA inhibits the reaction [cholesterol results in increased phosphorylation of GSK3B protein]|cyp7a1 mRNA inhibits the reaction [cholesterol results in increased phosphorylation of RPS6 protein],,,PMID:28275691,https://www.ncbi.nlm.nih.gov/pubmed/28275691,28275691,,
207,324789,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,9606.0,Homo sapiens (human),CYP7A1 mRNA inhibits the reaction [tretinoin results in increased abundance of cholesterol],,,PMID:30709899,https://www.ncbi.nlm.nih.gov/pubmed/30709899,30709899,,
208,324790,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,9606.0,Homo sapiens (human),CYP7A1 protein affects the metabolism of cholesterol,,,PMID:15696852,https://www.ncbi.nlm.nih.gov/pubmed/15696852,15696852,,
209,324791,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,9606.0,Homo sapiens (human),CYP7A1 protein results in increased metabolism of cholesterol,,,PMID:11013305|PMID:7925343,https://www.ncbi.nlm.nih.gov/pubmed/11013305|https://www.ncbi.nlm.nih.gov/pubmed/7925343,11013305|7925343,,
210,324792,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10036.0,Mesocricetus auratus (golden hamster),[[cajanus cajan extract results in increased expression of CYP7A1 mrna] co-treated with [cajanus cajan extract results in increased expression of LDLR mrna]] results in decreased abundance of cholesterol|[[[cajanus cajan extract results in increased expression of CYP7A1 mrna] co-treated with [cajanus cajan extract results in increased expression of LDLR mrna]] results in increased metabolism of cholesterol] which results in increased chemical synthesis of bile acids and salts|[[cajanus cajan extract results in increased expression of CYP7A1 mrna] co-treated with [cajanus cajan extract results in increased expression of LDLR mrna]] results in increased metabolism of cholesterol,,,PMID:23287313,https://www.ncbi.nlm.nih.gov/pubmed/23287313,23287313,,
211,324793,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10116.0,Rattus norvegicus (Norway rat),Turmeric extract promotes the reaction [cholesterol results in increased expression of CYP7A1 mrna]|cholesterol results in increased expression of CYP7A1 mRNA,,,PMID:21535835,https://www.ncbi.nlm.nih.gov/pubmed/21535835,21535835,,
212,324794,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,10116.0,Rattus norvegicus (Norway rat),CYP7A1 protein results in increased metabolism of cholesterol,,,PMID:1175606,https://www.ncbi.nlm.nih.gov/pubmed/1175606,1175606,,
213,324795,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,9606.0,Homo sapiens (human),[CYP7A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of bile acids and salts|cyp7a1 protein results in increased metabolism of cholesterol,,,PMID:12700418,https://www.ncbi.nlm.nih.gov/pubmed/12700418,12700418,,
214,324964,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1581,CYP7A1,https://ctdbase.org/detail.go?type=gene&acc=1581,,,1581.0,CYP7A1,9606.0,Homo sapiens (human),"[CYP7A1 protein results in increased oxidation of cholesterol] which results in increased chemical synthesis of cholest-5-en-3 beta,7 alpha-diol",,,PMID:11514559,https://www.ncbi.nlm.nih.gov/pubmed/11514559,11514559,,
215,324965,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9420,CYP7B1,https://ctdbase.org/detail.go?type=gene&acc=9420,,,9420.0,CYP7B1,10116.0,Rattus norvegicus (Norway rat),Cholesterol results in increased activity of CYP7B1 protein|cholesterol results in increased expression of CYP7B1 mRNA,,,PMID:12029625,https://www.ncbi.nlm.nih.gov/pubmed/12029625,12029625,,
216,324966,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1612,DAPK1,https://ctdbase.org/detail.go?type=gene&acc=1612,,,1612.0,DAPK1,10116.0,Rattus norvegicus (Norway rat),"Acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of DAPK1 mrna]|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased expression of DAPK1 mrna]|cholesterol analog results in increased expression of DAPK1 mRNA",,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
217,324967,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,81501,DCSTAMP,https://ctdbase.org/detail.go?type=gene&acc=81501,,,81501.0,DCSTAMP,9606.0,Homo sapiens (human),CLEC4E protein promotes the reaction [cholesterol results in increased expression of DCSTAMP mrna]|cholesterol results in increased expression of DCSTAMP mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
218,324968,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649.0,DDIT3,10090.0,Mus musculus (house mouse),[bisphenol A co-treated with dietary fats co-treated with cholesterol co-treated with cholic acid] results in increased expression of DDIT3 protein|acetylcysteine inhibits the reaction [[bisphenol A co-treated with dietary fats co-treated with cholesterol co-treated with cholic acid] results in increased expression of DDIT3 protein],,,PMID:35622622,https://www.ncbi.nlm.nih.gov/pubmed/35622622,35622622,,
219,324969,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8694,DGAT1,https://ctdbase.org/detail.go?type=gene&acc=8694,,,8694.0,DGAT1,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose co-treated with ethinyl estradiol] results in increased expression of DGAT1 mrna|[lard co-treated with cholesterol co-treated with sucrose co-treated with cypermethrin] results in increased expression of DGAT1 mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
220,324970,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,84649,DGAT2,https://ctdbase.org/detail.go?type=gene&acc=84649,,,84649.0,DGAT2,10090.0,Mus musculus (house mouse),Ethinyl estradiol promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of DGAT2 mrna]|[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of DGAT2 mrna|atrazine promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of DGAT2 mrna],,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
221,324971,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1718,DHCR24,https://ctdbase.org/detail.go?type=gene&acc=1718,,,1718.0,DHCR24,9606.0,Homo sapiens (human),[DHCR24 protein results in increased metabolism of desmosterol] which results in increased abundance of cholesterol,,,PMID:23042211,https://www.ncbi.nlm.nih.gov/pubmed/23042211,23042211,,
222,324972,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1718,DHCR24,https://ctdbase.org/detail.go?type=gene&acc=1718,,,1718.0,DHCR24,10090.0,Mus musculus (house mouse),DHCR24 protein affects the abundance of cholesterol,,,PMID:19260826,https://www.ncbi.nlm.nih.gov/pubmed/19260826,19260826,,
223,325132,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1717,DHCR7,https://ctdbase.org/detail.go?type=gene&acc=1717,,,1717.0,DHCR7,9606.0,Homo sapiens (human),DHCR7 mutant form affects the susceptibility to cholesterol,,,PMID:19365639,https://www.ncbi.nlm.nih.gov/pubmed/19365639,19365639,,
224,325133,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1717,DHCR7,https://ctdbase.org/detail.go?type=gene&acc=1717,,,1717.0,DHCR7,9606.0,Homo sapiens (human),DHCR7 mutant form results in decreased abundance of cholesterol,,,PMID:16446309,https://www.ncbi.nlm.nih.gov/pubmed/16446309,16446309,,
225,325134,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1717,DHCR7,https://ctdbase.org/detail.go?type=gene&acc=1717,,,1717.0,DHCR7,9606.0,Homo sapiens (human),DHCR7 results in increased chemical synthesis of cholesterol|simvastatin promotes the reaction [DHCR7 results in increased chemical synthesis of cholesterol],,,PMID:15896653,https://www.ncbi.nlm.nih.gov/pubmed/15896653,15896653,,
226,325135,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733.0,DIO1,10116.0,Rattus norvegicus (Norway rat),Cholesterol affects the expression of DIO1 mRNA,,,PMID:16874406,https://www.ncbi.nlm.nih.gov/pubmed/16874406,16874406,,
227,325136,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1733,DIO1,https://ctdbase.org/detail.go?type=gene&acc=1733,,,1733.0,DIO1,10116.0,Rattus norvegicus (Norway rat),Cholesterol results in decreased activity of DIO1 protein|cholesterol results in decreased expression of DIO1 mRNA,,,PMID:16271152,https://www.ncbi.nlm.nih.gov/pubmed/16271152,16271152,,
228,325137,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1734,DIO2,https://ctdbase.org/detail.go?type=gene&acc=1734,,,1734.0,DIO2,9606.0,Homo sapiens (human),Cholesterol results in increased degradation of DIO2 protein,,,PMID:30545937,https://www.ncbi.nlm.nih.gov/pubmed/30545937,30545937,,
229,325138,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1950,EGF,https://ctdbase.org/detail.go?type=gene&acc=1950,,,1950.0,EGF,9606.0,Homo sapiens (human),"[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the expression of SOD2 mrna|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in decreased expression of TP53 mrna|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] affects the expression of SOD2 mrna|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in increased activity of CASP9 protein|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] results in increased expression of TP53 mrna|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds affects the abundance of reactive oxygen species]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] promotes the reaction [silver compounds results in increased activity of CASP9 protein]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds affects the expression of MKI67 mrna]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the expression of CAT mrna|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds affects the expression of SOD2 mrna]|egf protein affects the susceptibility to [[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds affects the expression of CAT mrna]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds results in decreased activity of CAT protein]|[egf protein co-treated with [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]]] inhibits the reaction [[EGF protein co-treated with silver compounds] results in decreased expression of MKI67 protein]|[egf protein co-treated with [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]]] inhibits the reaction [[EGF protein co-treated with silver compounds] results in increased activity of CAT protein]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] inhibits the reaction [silver compounds results in increased activity of CASP3 protein]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds results in decreased expression of MKI67 protein]|egf protein inhibits the reaction [[[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] affects the abundance of reactive oxygen species]|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in increased expression of MKI67 mrna|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] promotes the reaction [silver compounds results in increased activity of CASP3 protein]|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in decreased expression of CAT mrna|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] affects the abundance of reactive oxygen species|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the expression of MKI67 mrna|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in increased activity of CASP3 protein|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the abundance of reactive oxygen species|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] results in increased expression of MKI67 protein|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] results in decreased activity of CASP3 protein|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds affects the expression of TP53 mrna]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with",,,PMID:35385781,https://www.ncbi.nlm.nih.gov/pubmed/35385781,35385781,,
230,325139,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of EGFR mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
231,325140,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965.0,EIF2S1,10090.0,Mus musculus (house mouse),EIF2S1 protein modified form results in decreased abundance of cholesterol,,,PMID:16330322,https://www.ncbi.nlm.nih.gov/pubmed/16330322,16330322,,
232,325141,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1973,EIF4A1,https://ctdbase.org/detail.go?type=gene&acc=1973,,,1973.0,EIF4A1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of EIF4A1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
233,325313,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978.0,EIF4EBP1,9606.0,Homo sapiens (human),Cholesterol results in increased phosphorylation of EIF4EBP1 protein|cyp7a1 mRNA inhibits the reaction [cholesterol results in increased phosphorylation of EIF4EBP1 protein],,,PMID:28275691,https://www.ncbi.nlm.nih.gov/pubmed/28275691,28275691,,
234,325314,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2035,EPB41,https://ctdbase.org/detail.go?type=gene&acc=2035,,,2035.0,EPB41,10116.0,Rattus norvegicus (Norway rat),[hydrogen peroxide co-treated with cholesterol] results in increased degradation of EPB41 protein|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [[hydrogen peroxide co-treated with cholesterol] results in increased degradation of EPB41 protein]|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [[hydrogen peroxide co-treated with cholesterol] results in decreased expression of and affects the localization of EPB41 protein]|[hydrogen peroxide co-treated with cholesterol] results in decreased expression of and affects the localization of EPB41 protein,,,PMID:20946910,https://www.ncbi.nlm.nih.gov/pubmed/20946910,20946910,,
235,325315,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,11082,ESM1,https://ctdbase.org/detail.go?type=gene&acc=11082,,,11082.0,ESM1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of ESM1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
236,325316,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of FABP1 protein,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
237,325317,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8772,FADD,https://ctdbase.org/detail.go?type=gene&acc=8772,,,8772.0,FADD,10116.0,Rattus norvegicus (Norway rat),Cholesterol results in increased expression of FADD protein|hydrogen peroxide promotes the reaction [cholesterol results in increased expression of FADD protein]|cholesterol promotes the reaction [hydrogen peroxide results in increased expression of FADD protein],,,PMID:20946910,https://www.ncbi.nlm.nih.gov/pubmed/20946910,20946910,,
238,325318,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [FGF7 protein results in increased expression of FAS mrna],,,PMID:16162944,https://www.ncbi.nlm.nih.gov/pubmed/16162944,16162944,,
239,325319,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of FAS mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
240,325320,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,10116.0,Rattus norvegicus (Norway rat),"Acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of FAS mrna]|cholesterol analog results in increased expression of FAS mrna|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased expression of FAS mrna]",,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
241,325321,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in increased expression of FASLG protein,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
242,325478,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222.0,FDFT1,9606.0,Homo sapiens (human),FDFT1 protein results in increased chemical synthesis of cholesterol,,,PMID:17483544,https://www.ncbi.nlm.nih.gov/pubmed/17483544,17483544,,
243,325479,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9965,FGF19,https://ctdbase.org/detail.go?type=gene&acc=9965,,,9965.0,FGF19,9606.0,Homo sapiens (human),[FGF19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of cholesterol|src protein promotes the reaction [[FGF19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of cholesterol]|nr1h4 protein mutant form inhibits the reaction [[FGF19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of cholesterol]|dasatinib inhibits the reaction [[FGF19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of cholesterol],,,PMID:30996006,https://www.ncbi.nlm.nih.gov/pubmed/30996006,30996006,,
244,325480,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2252,FGF7,https://ctdbase.org/detail.go?type=gene&acc=2252,,,2252.0,FGF7,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [FGF7 protein results in increased expression of FAS mrna]|cholesterol inhibits the reaction [FGF7 protein results in increased expression of SCD mrna],,,PMID:16162944,https://www.ncbi.nlm.nih.gov/pubmed/16162944,16162944,,
245,325481,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2252,FGF7,https://ctdbase.org/detail.go?type=gene&acc=2252,,,2252.0,FGF7,10116.0,Rattus norvegicus (Norway rat),"[1,2-dioleoyloxy-3-(trimethylammonium)propane co-treated with cholesterol] results in increased expression of FGF7 protein",,,PMID:16034455,https://www.ncbi.nlm.nih.gov/pubmed/16034455,16034455,,
246,325482,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2264,FGFR4,https://ctdbase.org/detail.go?type=gene&acc=2264,,,2264.0,FGFR4,9606.0,Homo sapiens (human),FGFR4 protein results in decreased metabolism of cholesterol,,,PMID:15750181,https://www.ncbi.nlm.nih.gov/pubmed/15750181,15750181,,
247,325483,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2264,FGFR4,https://ctdbase.org/detail.go?type=gene&acc=2264,,,2264.0,FGFR4,10090.0,Mus musculus (house mouse),FGFR4 protein affects the metabolism of cholesterol,,,PMID:11956156,https://www.ncbi.nlm.nih.gov/pubmed/11956156,11956156,,
248,325484,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2321,FLT1,https://ctdbase.org/detail.go?type=gene&acc=2321,,,2321.0,FLT1,9606.0,Homo sapiens (human),Cholesterol results in increased expression of FLT1 mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
249,325485,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10912,GADD45G,https://ctdbase.org/detail.go?type=gene&acc=10912,,,10912.0,GADD45G,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GADD45G mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
250,325486,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2634,GBP2,https://ctdbase.org/detail.go?type=gene&acc=2634,,,2634.0,GBP2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GBP2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
251,325487,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,115361,GBP4,https://ctdbase.org/detail.go?type=gene&acc=115361,,,115361.0,GBP4,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GBP4 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
252,325666,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,236573,GBP9,https://ctdbase.org/detail.go?type=gene&acc=236573,,,236573.0,Gbp9,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GBP9 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
253,325667,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of GCLC protein,,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
254,325668,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2705,GJB1,https://ctdbase.org/detail.go?type=gene&acc=2705,,,2705.0,GJB1,10090.0,Mus musculus (house mouse),GJB1 protein results in decreased abundance of cholesterol,,,PMID:27859493,https://www.ncbi.nlm.nih.gov/pubmed/27859493,27859493,,
255,325669,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2773,GNAI3,https://ctdbase.org/detail.go?type=gene&acc=2773,,,2773.0,GNAI3,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [progesterone results in decreased expression of GNAI3 protein],,,PMID:19221014,https://www.ncbi.nlm.nih.gov/pubmed/19221014,19221014,,
256,325670,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2778,GNAS,https://ctdbase.org/detail.go?type=gene&acc=2778,,,2778.0,GNAS,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [progesterone results in increased expression of GNAS protein],,,PMID:19221014,https://www.ncbi.nlm.nih.gov/pubmed/19221014,19221014,,
257,325671,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2811,GP1BA,https://ctdbase.org/detail.go?type=gene&acc=2811,,,2811.0,GP1BA,9606.0,Homo sapiens (human),Cholesterol results in increased expression of GP1BA mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
258,325672,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,57678,GPAM,https://ctdbase.org/detail.go?type=gene&acc=57678,,,57678.0,GPAM,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose co-treated with atrazine] results in increased expression of GPAM mrna|[lard co-treated with cholesterol co-treated with sucrose co-treated with ethinyl estradiol] results in increased expression of GPAM mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
259,325673,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of GPX2 mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
260,325674,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,9606.0,Homo sapiens (human),Cholesterol results in increased phosphorylation of GSK3B protein|cyp7a1 mRNA inhibits the reaction [cholesterol results in increased phosphorylation of GSK3B protein],,,PMID:28275691,https://www.ncbi.nlm.nih.gov/pubmed/28275691,28275691,,
261,325675,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116.0,Rattus norvegicus (Norway rat),Plant extracts inhibits the reaction [[streptozocin co-treated with coconut oil co-treated with cholesterol] results in decreased phosphorylation of GSK3B protein]|metformin inhibits the reaction [[streptozocin co-treated with coconut oil co-treated with cholesterol] results in decreased phosphorylation of GSK3B protein]|[streptozocin co-treated with coconut oil co-treated with cholesterol] results in decreased phosphorylation of GSK3B protein,,,PMID:31877369,https://www.ncbi.nlm.nih.gov/pubmed/31877369,31877369,,
262,325812,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,112495,GTF3C6,https://ctdbase.org/detail.go?type=gene&acc=112495,,,112495.0,GTF3C6,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GTF3C6 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
263,325813,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3001,GZMA,https://ctdbase.org/detail.go?type=gene&acc=3001,,,3001.0,GZMA,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GZMA mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
264,325814,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3002,GZMB,https://ctdbase.org/detail.go?type=gene&acc=3002,,,3002.0,GZMB,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of GZMB mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
265,325815,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,333715,H2-M10.2,https://ctdbase.org/detail.go?type=gene&acc=333715,,,333715.0,H2-M10.2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of H2-M10.2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
266,325816,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,15042,H2-T24,https://ctdbase.org/detail.go?type=gene&acc=15042,,,15042.0,H2-T24,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of H2-T24 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
267,325817,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,26061,HACL1,https://ctdbase.org/detail.go?type=gene&acc=26061,,,26061.0,HACL1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of HACL1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
268,325818,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,26762,HAVCR1,https://ctdbase.org/detail.go?type=gene&acc=26762,,,26762.0,HAVCR1,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of HAVCR1 mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
269,325819,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1839,HBEGF,https://ctdbase.org/detail.go?type=gene&acc=1839,,,1839.0,HBEGF,9606.0,Homo sapiens (human),Cholesterol results in increased expression of HBEGF mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
270,325820,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,9606.0,Homo sapiens (human),[HCAR2 protein results in decreased expression of ABCA1 protein] which results in decreased export of cholesterol|[[niacin binds to and results in increased activity of HCAR2 protein] which results in decreased expression of ABCA1 protein] which results in decreased export of cholesterol,,,PMID:20655299,https://www.ncbi.nlm.nih.gov/pubmed/20655299,20655299,,
271,325821,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,338442,HCAR2,https://ctdbase.org/detail.go?type=gene&acc=338442,,,338442.0,HCAR2,10090.0,Mus musculus (house mouse),HCAR2 protein inhibits the reaction [[niacin results in increased expression of ABCG1 protein] which results in increased export of cholesterol],,,PMID:21317532,https://www.ncbi.nlm.nih.gov/pubmed/21317532,21317532,,
272,325957,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3091,HIF1A,https://ctdbase.org/detail.go?type=gene&acc=3091,,,3091.0,HIF1A,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of HIF1A mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
273,325958,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10029.0,Cricetulus griseus (Chinese hamster),Cholesterol results in decreased activity of HMGCR protein,,,PMID:10561571,https://www.ncbi.nlm.nih.gov/pubmed/10561571,10561571,,
274,325959,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),[25-hydroxycholesterol co-treated with cholesterol] results in decreased activity of HMGCR protein|ldlr gene mutant form promotes the reaction [[25-hydroxycholesterol co-treated with cholesterol] results in decreased activity of HMGCR protein],,,PMID:12477733,https://www.ncbi.nlm.nih.gov/pubmed/12477733,12477733,,
275,325960,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),[[artemisic acid results in decreased expression of CEBPA mrna] which results in decreased expression of HMGCR mrna] which results in decreased chemical synthesis of cholesterol|[artemisic acid results in decreased expression of HMGCR protein] which results in decreased chemical synthesis of cholesterol,,,PMID:23063590,https://www.ncbi.nlm.nih.gov/pubmed/23063590,23063590,,
276,325961,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),Cholesterol results in decreased activity of HMGCR protein,,,PMID:18024962,https://www.ncbi.nlm.nih.gov/pubmed/18024962,18024962,,
277,325962,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),Cholesterol results in decreased expression of HMGCR mRNA,,,PMID:17516993,https://www.ncbi.nlm.nih.gov/pubmed/17516993,17516993,,
278,325963,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),[clozapine results in increased activity of HMGCR protein] which results in increased abundance of cholesterol|[haloperidol results in increased activity of HMGCR protein] which results in increased abundance of cholesterol,,,PMID:16027736,https://www.ncbi.nlm.nih.gov/pubmed/16027736,16027736,,
279,325964,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),[[CYP27A1 protein results in increased metabolism of cholesterol] which results in increased chemical synthesis of 27-hydroxycholesterol] which results in increased activity of HMGCR protein,,,PMID:11408283,https://www.ncbi.nlm.nih.gov/pubmed/11408283,11408283,,
280,325965,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,406910,MIR125A,https://ctdbase.org/detail.go?type=gene&acc=406910,,,406910.0,MIR125A,9606.0,Homo sapiens (human),MIR125A mRNA results in decreased export of cholesterol,,,PMID:33952798,https://www.ncbi.nlm.nih.gov/pubmed/33952798,33952798,,
281,325966,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),Atorvastatin inhibits the reaction [[cholesterol co-treated with cholic acid] results in increased activity of HMGCR protein]|[cholesterol co-treated with cholic acid] results in decreased expression of HMGCR mrna|atorvastatin inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased expression of HMGCR mrna]|proanthocyanidins inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased expression of HMGCR mrna]|proanthocyanidins inhibits the reaction [[cholesterol co-treated with cholic acid] results in increased activity of HMGCR protein]|[cholesterol co-treated with cholic acid] results in increased activity of HMGCR protein,,,PMID:30273964,https://www.ncbi.nlm.nih.gov/pubmed/30273964,30273964,,
282,326155,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),Selenium promotes the reaction [cholesterol results in decreased expression of HMGCR mrna]|cholesterol results in decreased expression of HMGCR mRNA,,,PMID:16581047,https://www.ncbi.nlm.nih.gov/pubmed/16581047,16581047,,
283,326156,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,10116.0,Rattus norvegicus (Norway rat),[turmeric extract co-treated with cholesterol] results in decreased expression of HMGCR mRNA,,,PMID:21535835,https://www.ncbi.nlm.nih.gov/pubmed/21535835,21535835,,
284,326157,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606.0,Homo sapiens (human),HMGCR protein results in increased chemical synthesis of cholesterol,,,PMID:12700418,https://www.ncbi.nlm.nih.gov/pubmed/12700418,12700418,,
285,326158,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with particulate matter] results in increased expression of HMOX1 mrna|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [cholesterol results in increased expression of HMOX1 mrna]]|particulate matter promotes the reaction [cholesterol results in increased expression of HMOX1 mrna]|cholesterol results in increased expression of HMOX1 mRNA,,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
286,326159,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Turmeric extract inhibits the reaction [cholesterol results in decreased expression of HMOX1 mrna]|cholesterol results in decreased expression of HMOX1 mRNA,,,PMID:21535835,https://www.ncbi.nlm.nih.gov/pubmed/21535835,21535835,,
287,326160,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of HMOX1 mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
288,326161,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3172,HNF4A,https://ctdbase.org/detail.go?type=gene&acc=3172,,,3172.0,HNF4A,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with cholic acid] results in decreased expression of HNF4A mrna|proanthocyanidins inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased expression of HNF4A mrna]|atorvastatin inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased expression of HNF4A mrna],,,PMID:30273964,https://www.ncbi.nlm.nih.gov/pubmed/30273964,30273964,,
289,326162,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of ICAM1 protein]|[cholesterol co-treated with ergosterol] results in increased expression of ICAM1 protein|[cholesterol co-treated with ergosterol] results in increased expression of ICAM1 mrna|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of ICAM1 mrna],,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
290,326163,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,217845,IFI27L2B,https://ctdbase.org/detail.go?type=gene&acc=217845,,,217845.0,Ifi27l2b,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IFI27L2B mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
291,326315,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10561,IFI44,https://ctdbase.org/detail.go?type=gene&acc=10561,,,10561.0,IFI44,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IFI44 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
292,326316,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3437,IFIT3,https://ctdbase.org/detail.go?type=gene&acc=3437,,,3437.0,IFIT3,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IFIT3 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
293,326317,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with particulate matter] results in increased expression of IFNG protein|alpha-linolenic acid inhibits the reaction [[cholesterol co-treated with particulate matter] results in increased expression of IFNG protein],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
294,326318,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,10116.0,Rattus norvegicus (Norway rat),"[1,2-dioleoyloxy-3-(trimethylammonium)propane co-treated with cholesterol] results in increased expression of IGF1 protein",,,PMID:16034455,https://www.ncbi.nlm.nih.gov/pubmed/16034455,16034455,,
295,326319,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3482,IGF2R,https://ctdbase.org/detail.go?type=gene&acc=3482,,,3482.0,IGF2R,10116.0,Rattus norvegicus (Norway rat),[IGF2R protein alternative form results in increased susceptibility to streptozocin] which results in increased abundance of cholesterol,,,PMID:35993117,https://www.ncbi.nlm.nih.gov/pubmed/35993117,35993117,,
296,326320,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3484,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484.0,IGFBP1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IGFBP1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
297,326321,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3486,IGFBP3,https://ctdbase.org/detail.go?type=gene&acc=3486,,,3486.0,IGFBP3,10116.0,Rattus norvegicus (Norway rat),"[1,2-dioleoyloxy-3-(trimethylammonium)propane co-treated with cholesterol] results in increased expression of IGFBP3 protein",,,PMID:16034455,https://www.ncbi.nlm.nih.gov/pubmed/16034455,16034455,,
298,326322,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10068,IL18BP,https://ctdbase.org/detail.go?type=gene&acc=10068,,,10068.0,IL18BP,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IL18BP mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
299,326323,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),CLEC4E protein promotes the reaction [[cholesterol co-treated with lipopolysaccharides] results in increased expression of IL1B protein]|cholesterol results in increased expression of IL1B mrna|[cholesterol co-treated with lipopolysaccharides] results in increased expression of IL1B protein,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
300,326324,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Amitriptyline inhibits the reaction [cholesterol analog results in increased expression of IL1B protein]|smpd1 protein affects the reaction [cholesterol analog results in increased expression of IL1B protein]|cholesterol analog results in increased expression of IL1B protein,,,PMID:28633109,https://www.ncbi.nlm.nih.gov/pubmed/28633109,28633109,,
301,326464,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090.0,Mus musculus (house mouse),Quercetin inhibits the reaction [cholesterol promotes the reaction [lipopolysaccharides results in increased secretion of IL1B protein]]|cholesterol promotes the reaction [lipopolysaccharides results in increased secretion of IL1B protein],,,PMID:22869926,https://www.ncbi.nlm.nih.gov/pubmed/22869926,22869926,,
302,326465,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with particulate matter] results in increased expression of IL1B protein|alpha-linolenic acid inhibits the reaction [[cholesterol co-treated with particulate matter] results in increased expression of IL1B protein]|cholesterol results in increased expression of IL1B protein,,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
303,326466,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,114548,NLRP3,https://ctdbase.org/detail.go?type=gene&acc=114548,,,114548.0,NLRP3,10090.0,Mus musculus (house mouse),SMPD1 protein affects the reaction [cholesterol analog affects the localization of NLRP3 protein]|amitriptyline inhibits the reaction [cholesterol analog affects the localization of NLRP3 protein]|cholesterol analog affects the localization of NLRP3 protein,,,PMID:28633109,https://www.ncbi.nlm.nih.gov/pubmed/28633109,28633109,,
304,326467,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of IL1B mrna]|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of and results in increased secretion of IL1B protein]|[cholesterol co-treated with ergosterol] results in increased expression of IL1B mrna|[cholesterol co-treated with ergosterol] results in increased expression of and results in increased secretion of IL1B protein,,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
305,326468,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of IL1B mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
306,326469,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,9606.0,Homo sapiens (human),IL1B protein results in decreased transport of cholesterol|[pirinixic acid binds to and results in increased activity of PPARA protein] inhibits the reaction [IL1B protein results in decreased transport of cholesterol]|[il1b protein results in decreased expression of ABCA1 mrna] which results in decreased transport of cholesterol|[il1b protein results in decreased expression of ABCA1 mrna] which results in increased abundance of cholesterol|[bezafibrate binds to and results in increased activity of PPARA protein] inhibits the reaction [IL1B protein results in decreased transport of cholesterol]|il1b protein results in increased abundance of cholesterol,,,PMID:12595494,https://www.ncbi.nlm.nih.gov/pubmed/12595494,12595494,,
307,326470,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3557,IL1RN,https://ctdbase.org/detail.go?type=gene&acc=3557,,,3557.0,IL1RN,9606.0,Homo sapiens (human),Cholesterol results in increased expression of IL1RN mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
308,326471,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [irbesartan results in increased expression of IL6 protein]|cholesterol inhibits the reaction [irbesartan results in increased expression of IL6 mrna]|cholesterol results in increased expression of IL6 protein|cholesterol results in increased expression of IL6 mRNA,,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
309,326614,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116.0,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [cholesterol promotes the reaction [particulate matter results in increased expression of IL6 protein]]|cholesterol promotes the reaction [particulate matter results in increased expression of IL6 protein]|[cholesterol co-treated with particulate matter] results in increased expression of IL6 mRNA,,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
310,326615,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3624,INHBA,https://ctdbase.org/detail.go?type=gene&acc=3624,,,3624.0,INHBA,9606.0,Homo sapiens (human),Cholesterol results in increased expression of INHBA mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
311,326616,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,10090.0,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased abundance of cholesterol analog,,,PMID:26820058,https://www.ncbi.nlm.nih.gov/pubmed/26820058,26820058,,
312,326617,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10116.0,Rattus norvegicus (Norway rat),[streptozocin co-treated with coconut oil co-treated with cholesterol] results in increased expression of INS1 protein|plant extracts inhibits the reaction [[streptozocin co-treated with coconut oil co-treated with cholesterol] results in increased expression of INS1 protein]|metformin inhibits the reaction [[streptozocin co-treated with coconut oil co-treated with cholesterol] results in increased expression of INS1 protein],,,PMID:31877369,https://www.ncbi.nlm.nih.gov/pubmed/31877369,31877369,,
313,326618,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3638,INSIG1,https://ctdbase.org/detail.go?type=gene&acc=3638,,,3638.0,INSIG1,10029.0,Cricetulus griseus (Chinese hamster),[25-hydroxycholesterol co-treated with cholesterol] promotes the reaction [SCAP protein binds to INSIG1 protein],,,PMID:19716478,https://www.ncbi.nlm.nih.gov/pubmed/19716478,19716478,,
314,326619,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3665,IRF7,https://ctdbase.org/detail.go?type=gene&acc=3665,,,3665.0,IRF7,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of IRF7 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
315,326620,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3667,IRS1,https://ctdbase.org/detail.go?type=gene&acc=3667,,,3667.0,IRS1,9606.0,Homo sapiens (human),IRS1 gene polymorphism affects the abundance of cholesterol,,,PMID:10591678,https://www.ncbi.nlm.nih.gov/pubmed/10591678,10591678,,
316,326621,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9636,ISG15,https://ctdbase.org/detail.go?type=gene&acc=9636,,,9636.0,ISG15,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of ISG15 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
317,326622,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3757,KCNH2,https://ctdbase.org/detail.go?type=gene&acc=3757,,,3757.0,KCNH2,10116.0,Rattus norvegicus (Norway rat),Cholesterol results in decreased localization of KCNH2 protein,,,PMID:21525004,https://www.ncbi.nlm.nih.gov/pubmed/21525004,21525004,,
318,326623,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4254,KITLG,https://ctdbase.org/detail.go?type=gene&acc=4254,,,4254.0,KITLG,9606.0,Homo sapiens (human),Cholesterol results in increased expression of KITLG mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
319,326765,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3880,KRT19,https://ctdbase.org/detail.go?type=gene&acc=3880,,,3880.0,KRT19,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [arachidonyl dopamine results in increased expression of KRT19 mrna],,,PMID:33393692,https://www.ncbi.nlm.nih.gov/pubmed/33393692,33393692,,
320,326766,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3916,LAMP1,https://ctdbase.org/detail.go?type=gene&acc=3916,,,3916.0,LAMP1,9606.0,Homo sapiens (human),Cholesterol results in increased expression of LAMP1 protein,,,PMID:28275691,https://www.ncbi.nlm.nih.gov/pubmed/28275691,28275691,,
321,326767,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3931,LCAT,https://ctdbase.org/detail.go?type=gene&acc=3931,,,3931.0,LCAT,9606.0,Homo sapiens (human),LCAT protein results in increased acylation of cholesterol,,,PMID:4847537,https://www.ncbi.nlm.nih.gov/pubmed/4847537,4847537,,
322,326768,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [nicotine results in increased phosphorylation of RPS6 protein],,,PMID:31629012,https://www.ncbi.nlm.nih.gov/pubmed/31629012,31629012,,
323,326769,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3931,LCAT,https://ctdbase.org/detail.go?type=gene&acc=3931,,,3931.0,LCAT,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with cholic acid] results in increased activity of LCAT protein|atorvastatin inhibits the reaction [[cholesterol co-treated with cholic acid] results in increased activity of LCAT protein]|proanthocyanidins inhibits the reaction [[cholesterol co-treated with cholic acid] results in increased activity of LCAT protein],,,PMID:30273964,https://www.ncbi.nlm.nih.gov/pubmed/30273964,30273964,,
324,326770,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3934,LCN2,https://ctdbase.org/detail.go?type=gene&acc=3934,,,3934.0,LCN2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of LCN2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
325,326771,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606.0,Homo sapiens (human),LDLR protein results in increased uptake of cholesterol|[cyp27a1 protein results in increased chemical synthesis of bile acids and salts] promotes the reaction [LDLR protein results in increased uptake of cholesterol],,,PMID:16477808,https://www.ncbi.nlm.nih.gov/pubmed/16477808,16477808,,
326,326772,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606.0,Homo sapiens (human),LDLR gene mutant form promotes the reaction [[25-hydroxycholesterol co-treated with cholesterol] results in decreased activity of HMGCR protein]|ldlr gene mutant form results in increased susceptibility to [25-hydroxycholesterol co-treated with cholesterol],,,PMID:12477733,https://www.ncbi.nlm.nih.gov/pubmed/12477733,12477733,,
327,326773,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10036.0,Mesocricetus auratus (golden hamster),[[cajanus cajan extract results in increased expression of CYP7A1 mrna] co-treated with [cajanus cajan extract results in increased expression of LDLR mrna]] results in decreased abundance of cholesterol|[[[cajanus cajan extract results in increased expression of CYP7A1 mrna] co-treated with [cajanus cajan extract results in increased expression of LDLR mrna]] results in increased metabolism of cholesterol] which results in increased chemical synthesis of bile acids and salts|[[cajanus cajan extract results in increased expression of CYP7A1 mrna] co-treated with [cajanus cajan extract results in increased expression of LDLR mrna]] results in increased metabolism of cholesterol,,,PMID:23287313,https://www.ncbi.nlm.nih.gov/pubmed/23287313,23287313,,
328,326972,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10090.0,Mus musculus (house mouse),[LDLR gene mutant form results in increased susceptibility to dietary fats] which results in increased abundance of cholesterol|argatroban inhibits the reaction [[LDLR gene mutant form results in increased susceptibility to dietary fats] which results in increased abundance of cholesterol],,,PMID:22841818,https://www.ncbi.nlm.nih.gov/pubmed/22841818,22841818,,
329,326973,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10090.0,Mus musculus (house mouse),SORT1 protein affects the reaction [LDLR protein affects the abundance of cholesterol]|ldlr protein affects the abundance of cholesterol|chloroquine affects the reaction [SORT1 protein affects the reaction [LDLR protein affects the abundance of cholesterol]],,,PMID:30950489,https://www.ncbi.nlm.nih.gov/pubmed/30950489,30950489,,
330,326974,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10090.0,Mus musculus (house mouse),LDLR gene mutant form results in increased susceptibility to cholesterol|(+)-JQ1 compound inhibits the reaction [LDLR gene mutant form results in increased susceptibility to cholesterol],,,PMID:25263595,https://www.ncbi.nlm.nih.gov/pubmed/25263595,25263595,,
331,326975,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10090.0,Mus musculus (house mouse),[tobacco smoke pollution promotes the reaction [LDLR protein affects the susceptibility to dietary fats]] which results in increased abundance of cholesterol,,,PMID:22659316,https://www.ncbi.nlm.nih.gov/pubmed/22659316,22659316,,
332,326976,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10116.0,Rattus norvegicus (Norway rat),Proanthocyanidins inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased expression of LDLR mrna]|[cholesterol co-treated with cholic acid] results in decreased expression of LDLR mrna|atorvastatin inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased expression of LDLR mrna],,,PMID:30273964,https://www.ncbi.nlm.nih.gov/pubmed/30273964,30273964,,
333,326977,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10116.0,Rattus norvegicus (Norway rat),Cholesterol inhibits the reaction [[cholesterol deficiency co-treated with lovastatin] results in increased expression of LDLR mrna]|[cholesterol deficiency co-treated with lovastatin] results in increased expression of LDLR mRNA,,,PMID:20578043,https://www.ncbi.nlm.nih.gov/pubmed/20578043,20578043,,
334,326978,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10116.0,Rattus norvegicus (Norway rat),Cholesterol results in decreased activity of LDLR protein,,,PMID:16271152|PMID:16317514|PMID:16937255,https://www.ncbi.nlm.nih.gov/pubmed/16271152|https://www.ncbi.nlm.nih.gov/pubmed/16317514|https://www.ncbi.nlm.nih.gov/pubmed/16937255,16271152|16317514|16937255,,
335,326979,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10116.0,Rattus norvegicus (Norway rat),Cholesterol results in decreased expression of LDLR mRNA,,,PMID:16271152|PMID:16317514|PMID:16937255|PMID:21535835,https://www.ncbi.nlm.nih.gov/pubmed/16271152|https://www.ncbi.nlm.nih.gov/pubmed/16317514|https://www.ncbi.nlm.nih.gov/pubmed/16937255|https://www.ncbi.nlm.nih.gov/pubmed/21535835,16271152|16317514|16937255|21535835,,
336,326980,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10116.0,Rattus norvegicus (Norway rat),Selenium inhibits the reaction [cholesterol results in decreased expression of LDLR mrna]|selenium inhibits the reaction [cholesterol results in decreased activity of LDLR protein],,,PMID:16937255,https://www.ncbi.nlm.nih.gov/pubmed/16937255,16937255,,
337,327154,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10116.0,Rattus norvegicus (Norway rat),Turmeric extract inhibits the reaction [cholesterol results in decreased expression of LDLR mrna]|[turmeric extract co-treated with cholesterol] results in increased expression of LDLR mRNA,,,PMID:21535835,https://www.ncbi.nlm.nih.gov/pubmed/21535835,21535835,,
338,327155,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952.0,LEP,9986.0,Oryctolagus cuniculus (rabbit),Cholesterol results in increased expression of LEP protein|niacin inhibits the reaction [cholesterol results in increased expression of LEP protein]|cholesterol results in increased expression of LEP mrna|niacin inhibits the reaction [cholesterol results in increased expression of LEP mrna],,,PMID:18402819,https://www.ncbi.nlm.nih.gov/pubmed/18402819,18402819,,
339,327156,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,3953,LEPR,https://ctdbase.org/detail.go?type=gene&acc=3953,,,3953.0,LEPR,10090.0,Mus musculus (house mouse),LEPR gene mutant form results in increased abundance of cholesterol|glucagon analog inhibits the reaction [LEPR gene mutant form results in increased abundance of cholesterol],,,PMID:29988851,https://www.ncbi.nlm.nih.gov/pubmed/29988851,29988851,,
340,327157,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,9606.0,Homo sapiens (human),Cholesterol results in increased expression of LPL mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
341,327158,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with cholic acid] results in increased activity of LPL protein|proanthocyanidins inhibits the reaction [[cholesterol co-treated with cholic acid] results in increased activity of LPL protein]|atorvastatin inhibits the reaction [[cholesterol co-treated with cholic acid] results in increased activity of LPL protein],,,PMID:30273964,https://www.ncbi.nlm.nih.gov/pubmed/30273964,30273964,,
342,327159,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,10090.0,Mus musculus (house mouse),[capsaicin results in decreased expression of LRP1 protein] which results in decreased uptake of cholesterol|[capsaicin results in decreased expression of LRP1 protein] which results in increased secretion of cholesterol,,,PMID:21908651,https://www.ncbi.nlm.nih.gov/pubmed/21908651,21908651,,
343,327160,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,110454,LY6A,https://ctdbase.org/detail.go?type=gene&acc=110454,,,110454.0,Ly6a,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of LY6A mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
344,327161,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,56778,LY6C,https://ctdbase.org/detail.go?type=gene&acc=56778,,,56778.0,Ly6c,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of LY6C mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
345,327162,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4061,LY6E,https://ctdbase.org/detail.go?type=gene&acc=4061,,,4061.0,LY6E,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of LY6E mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
346,327298,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,9606.0,Homo sapiens (human),Cholesterol results in increased expression of MAP1LC3B protein modified form,,,PMID:28275691,https://www.ncbi.nlm.nih.gov/pubmed/28275691,28275691,,
347,327299,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,81631,MAP1LC3B,https://ctdbase.org/detail.go?type=gene&acc=81631,,,81631.0,MAP1LC3B,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [cadmium chloride results in increased cleavage of MAP1LC3B protein],,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
348,327300,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with ergosterol] results in increased expression of MAPK14 mrna|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of MAPK14 mrna],,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
349,327301,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,10116.0,Rattus norvegicus (Norway rat),Selenium inhibits the reaction [[dietary fats co-treated with cholesterol] results in increased expression of MAPT protein modified form]|[dietary fats co-treated with cholesterol] results in increased expression of MAPT protein modified form,,,PMID:30695686,https://www.ncbi.nlm.nih.gov/pubmed/30695686,30695686,,
350,327302,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10299,MARCHF6,https://ctdbase.org/detail.go?type=gene&acc=10299,,,10299.0,MARCHF6,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [MARCHF6 protein results in increased ubiquitination of and results in increased degradation of MARCHF6 protein]|cholesterol results in increased stability of MARCHF6 protein|cholesterol inhibits the reaction [betaine results in decreased stability of MARCHF6 protein]|cholesterol inhibits the reaction [glycerol results in decreased stability of MARCHF6 protein]|marchf6 promotes the reaction [cholesterol results in increased degradation of SQLE protein],,,PMID:30545937,https://www.ncbi.nlm.nih.gov/pubmed/30545937,30545937,,
351,327303,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8685,MARCO,https://ctdbase.org/detail.go?type=gene&acc=8685,,,8685.0,MARCO,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MARCO mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
352,327304,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4253,MIA2,https://ctdbase.org/detail.go?type=gene&acc=4253,,,4253.0,MIA2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MIA2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
353,327305,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4288,MKI67,https://ctdbase.org/detail.go?type=gene&acc=4288,,,4288.0,MKI67,9606.0,Homo sapiens (human),"[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the expression of MKI67 mrna|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds results in decreased expression of MKI67 protein]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] results in increased expression of MKI67 protein|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in increased expression of MKI67 mrna|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in decreased expression of MKI67 protein|[egf protein co-treated with [[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]]] inhibits the reaction [[EGF protein co-treated with silver compounds] results in decreased expression of MKI67 protein]|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds affects the expression of MKI67 mrna]",,,PMID:35385781,https://www.ncbi.nlm.nih.gov/pubmed/35385781,35385781,,
354,327452,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,51085,MLXIPL,https://ctdbase.org/detail.go?type=gene&acc=51085,,,51085.0,MLXIPL,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of MLXIPL mrna|atrazine promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of MLXIPL mrna],,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
355,327453,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,219972,MPEG1,https://ctdbase.org/detail.go?type=gene&acc=219972,,,219972.0,MPEG1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MPEG1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
356,327454,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64380,MS4A4C,https://ctdbase.org/detail.go?type=gene&acc=64380,,,64380.0,Ms4a4c,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MS4A4C mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
357,327455,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4481,MSR1,https://ctdbase.org/detail.go?type=gene&acc=4481,,,4481.0,MSR1,9606.0,Homo sapiens (human),MSR1 protein results in increased uptake of cholesterol|[resveratrol results in decreased expression of MSR1 protein] which results in decreased uptake of cholesterol,,,PMID:20372816,https://www.ncbi.nlm.nih.gov/pubmed/20372816,20372816,,
358,327456,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,17748,MT1,https://ctdbase.org/detail.go?type=gene&acc=17748,,,17748.0,Mt1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MT1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
359,327457,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,17750,MT2,https://ctdbase.org/detail.go?type=gene&acc=17750,,,17750.0,Mt2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MT2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
360,327458,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,17750,MT2,https://ctdbase.org/detail.go?type=gene&acc=17750,,,17750.0,Mt2,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of MT2 protein,,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
361,327459,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,10090.0,Mus musculus (house mouse),Cholesterol results in increased phosphorylation of MTOR protein,,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
362,327460,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,620807,MUP6,https://ctdbase.org/detail.go?type=gene&acc=620807,,,620807.0,Mup6,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of MUP6 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
363,327461,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,9606.0,Homo sapiens (human),MVK protein mutant form results in decreased chemical synthesis of cholesterol,,,PMID:24073415,https://www.ncbi.nlm.nih.gov/pubmed/24073415,24073415,,
364,327613,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4638,MYLK,https://ctdbase.org/detail.go?type=gene&acc=4638,,,4638.0,MYLK,9986.0,Oryctolagus cuniculus (rabbit),Cholesterol results in increased activity of MYLK protein|cholesterol results in increased expression of MYLK protein|ml 7 inhibits the reaction [cholesterol results in increased activity of MYLK protein],,,PMID:21052790,https://www.ncbi.nlm.nih.gov/pubmed/21052790,21052790,,
365,327614,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4665,NAB2,https://ctdbase.org/detail.go?type=gene&acc=4665,,,4665.0,NAB2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of NAB2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
366,327615,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4669,NAGLU,https://ctdbase.org/detail.go?type=gene&acc=4669,,,4669.0,NAGLU,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of NAGLU protein,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
367,327616,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,653361,NCF1,https://ctdbase.org/detail.go?type=gene&acc=653361,,,653361.0,NCF1,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of NCF1 protein|cholesterol inhibits the reaction [irbesartan results in increased expression of NCF1 protein]|cholesterol inhibits the reaction [irbesartan results in increased expression of NCF1 mrna]|cholesterol results in increased expression of NCF1 mRNA,,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
368,327617,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10499,NCOA2,https://ctdbase.org/detail.go?type=gene&acc=10499,,,10499.0,NCOA2,10090.0,Mus musculus (house mouse),NCOA2 protein affects the metabolism of cholesterol,,,PMID:14993927,https://www.ncbi.nlm.nih.gov/pubmed/14993927,14993927,,
369,327618,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5819,NECTIN2,https://ctdbase.org/detail.go?type=gene&acc=5819,,,5819.0,NECTIN2,10090.0,Mus musculus (house mouse),Cholesterol affects the expression of NECTIN2,,,PMID:28062492,https://www.ncbi.nlm.nih.gov/pubmed/28062492,28062492,,
370,327619,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116.0,Rattus norvegicus (Norway rat),Cholesterol results in increased expression of NFE2L2 mrna|alpha-linolenic acid inhibits the reaction [cholesterol promotes the reaction [particulate matter results in increased expression of NFE2L2 mrna]]|cholesterol promotes the reaction [particulate matter results in increased expression of NFE2L2 protein]|particulate matter promotes the reaction [cholesterol results in increased expression of NFE2L2 mrna]|alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [cholesterol results in increased expression of NFE2L2 mrna]]|alpha-linolenic acid inhibits the reaction [cholesterol results in increased expression of NFE2L2 mrna],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
371,327620,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [irbesartan results in increased expression of NFKB1 protein]|cholesterol results in increased expression of NFKB1 protein,,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
372,327621,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4793,NFKBIB,https://ctdbase.org/detail.go?type=gene&acc=4793,,,4793.0,NFKBIB,10090.0,Mus musculus (house mouse),Cholesterol results in increased phosphorylation of NFKBIB protein|cholesterol inhibits the reaction [irbesartan results in increased phosphorylation of NFKBIB protein],,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
373,327824,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,114548,NLRP3,https://ctdbase.org/detail.go?type=gene&acc=114548,,,114548.0,NLRP3,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of NLRP3 protein]|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of NLRP3 mrna]|[cholesterol co-treated with ergosterol] results in increased expression of NLRP3 protein|[cholesterol co-treated with ergosterol] results in increased expression of NLRP3 mRNA,,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
374,327825,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9986.0,Oryctolagus cuniculus (rabbit),[estriol co-treated with cholesterol] results in increased expression of NOS2 protein|[estradiol co-treated with cholesterol] results in increased expression of NOS2 protein|cholesterol results in increased expression of NOS2 protein,,,PMID:12020746,https://www.ncbi.nlm.nih.gov/pubmed/12020746,12020746,,
375,327826,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,9986.0,Oryctolagus cuniculus (rabbit),[estradiol co-treated with cholesterol] results in increased expression of NOS3 mrna|cholesterol results in increased expression of NOS3 mrna|[estriol co-treated with cholesterol] results in increased expression of NOS3 mRNA,,,PMID:12020746,https://www.ncbi.nlm.nih.gov/pubmed/12020746,12020746,,
376,327827,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846.0,NOS3,9986.0,Oryctolagus cuniculus (rabbit),NOS3 protein results in decreased abundance of cholesterol,,,PMID:14736551,https://www.ncbi.nlm.nih.gov/pubmed/14736551,14736551,,
377,327828,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4864,NPC1,https://ctdbase.org/detail.go?type=gene&acc=4864,,,4864.0,NPC1,9606.0,Homo sapiens (human),NPC1 protein results in increased secretion of cholesterol|progesterone inhibits the reaction [NPC1 protein results in increased secretion of cholesterol],,,PMID:16174794,https://www.ncbi.nlm.nih.gov/pubmed/16174794,16174794,,
378,327829,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4864,NPC1,https://ctdbase.org/detail.go?type=gene&acc=4864,,,4864.0,NPC1,10090.0,Mus musculus (house mouse),NPC1 affects the localization of cholesterol,,,PMID:12183525,https://www.ncbi.nlm.nih.gov/pubmed/12183525,12183525,,
379,327830,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4864,NPC1,https://ctdbase.org/detail.go?type=gene&acc=4864,,,4864.0,NPC1,10090.0,Mus musculus (house mouse),NPC1 protein affects the abundance of cholesterol,,,PMID:18483620,https://www.ncbi.nlm.nih.gov/pubmed/18483620,18483620,,
380,327831,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,29881,NPC1L1,https://ctdbase.org/detail.go?type=gene&acc=29881,,,29881.0,NPC1L1,10090.0,Mus musculus (house mouse),[cholesterol deficiency co-treated with dietary fats] results in decreased expression of NPC1L1 mRNA,,,PMID:18356535,https://www.ncbi.nlm.nih.gov/pubmed/18356535,18356535,,
381,327832,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4868,NPHS1,https://ctdbase.org/detail.go?type=gene&acc=4868,,,4868.0,NPHS1,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in decreased expression of NPHS1 mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
382,327833,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10116.0,Rattus norvegicus (Norway rat),Alpha-linolenic acid inhibits the reaction [particulate matter promotes the reaction [cholesterol results in increased expression of NQO1 mrna]]|cholesterol results in increased expression of NQO1 mrna|particulate matter promotes the reaction [cholesterol results in increased expression of NQO1 mrna]|cholesterol promotes the reaction [particulate matter results in increased expression of NQO1 protein],,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
383,328019,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7376,NR1H2,https://ctdbase.org/detail.go?type=gene&acc=7376,,,7376.0,NR1H2,9606.0,Homo sapiens (human),Cholesterol results in increased activity of NR1H2 protein,,,PMID:21543282,https://www.ncbi.nlm.nih.gov/pubmed/21543282,21543282,,
384,328020,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7376,NR1H2,https://ctdbase.org/detail.go?type=gene&acc=7376,,,7376.0,NR1H2,10090.0,Mus musculus (house mouse),"NR1H2 gene mutant form inhibits the reaction [pitavastatin results in decreased export of cholesterol]|nr1h2 gene mutant form inhibits the reaction [pitavastatin inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-AMP results in increased export of cholesterol]]",,,PMID:16415093,https://www.ncbi.nlm.nih.gov/pubmed/16415093,16415093,,
385,328021,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7376,NR1H2,https://ctdbase.org/detail.go?type=gene&acc=7376,,,7376.0,NR1H2,10090.0,Mus musculus (house mouse),[RXRB protein binds to NR1H2 protein] which affects the metabolism of cholesterol,,,PMID:14993927,https://www.ncbi.nlm.nih.gov/pubmed/14993927,14993927,,
386,328022,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7376,NR1H2,https://ctdbase.org/detail.go?type=gene&acc=7376,,,7376.0,NR1H2,9606.0,Homo sapiens (human),NR1H2 protein affects the abundance of cholesterol,,,PMID:15914710,https://www.ncbi.nlm.nih.gov/pubmed/15914710,15914710,,
387,328023,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7376,NR1H2,https://ctdbase.org/detail.go?type=gene&acc=7376,,,7376.0,NR1H2,9606.0,Homo sapiens (human),NR1H2 protein affects the transport of cholesterol,,,PMID:15725701,https://www.ncbi.nlm.nih.gov/pubmed/15725701,15725701,,
388,328024,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9606.0,Homo sapiens (human),[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of cholesterol]|[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of cholesterol|[bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of cholesterol],,,PMID:12595494,https://www.ncbi.nlm.nih.gov/pubmed/12595494,12595494,,
389,328025,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9606.0,Homo sapiens (human),[cholesterol co-treated with ozone] results in increased lipidation of NR1H3 protein,,,PMID:27703007,https://www.ncbi.nlm.nih.gov/pubmed/27703007,27703007,,
390,328026,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9544.0,Macaca mulatta (Rhesus monkey),[27-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased export of cholesterol|[22-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased export of cholesterol|[t0901317 binds to and results in increased activity of NR1H3 protein] which results in increased export of cholesterol|[desmosterol binds to and results in increased activity of NR1H3 protein] which results in increased export of cholesterol,,,PMID:22156476,https://www.ncbi.nlm.nih.gov/pubmed/22156476,22156476,,
391,328027,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,10090.0,Mus musculus (house mouse),"NR1H3 gene mutant form inhibits the reaction [pitavastatin inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-AMP results in increased export of cholesterol]]|nr1h3 gene mutant form inhibits the reaction [pitavastatin results in decreased export of cholesterol]",,,PMID:16415093,https://www.ncbi.nlm.nih.gov/pubmed/16415093,16415093,,
392,328204,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9986.0,Oryctolagus cuniculus (rabbit),"[cholesterol, dietary results in decreased expression of NR1H3 mrna] which results in decreased export of cholesterol|niacin inhibits the reaction [[cholesterol, dietary results in decreased expression of NR1H3 mrna] which results in decreased export of cholesterol]",,,PMID:17395297,https://www.ncbi.nlm.nih.gov/pubmed/17395297,17395297,,
393,328205,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9986.0,Oryctolagus cuniculus (rabbit),Cholesterol results in decreased expression of NR1H3 mrna|niacin inhibits the reaction [cholesterol results in decreased expression of NR1H3 mrna]|niacin inhibits the reaction [[cholesterol results in decreased expression of NR1H3 mrna] which results in decreased export of cholesterol]|[cholesterol results in decreased expression of NR1H3 mrna] which results in decreased export of cholesterol,,,PMID:17963637,https://www.ncbi.nlm.nih.gov/pubmed/17963637,17963637,,
394,328206,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9986.0,Oryctolagus cuniculus (rabbit),[niacin results in increased expression of NR1H3 mrna] which results in increased export of cholesterol,,,PMID:17395297|PMID:17963637,https://www.ncbi.nlm.nih.gov/pubmed/17395297|https://www.ncbi.nlm.nih.gov/pubmed/17963637,17395297|17963637,,
395,328207,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9606.0,Homo sapiens (human),NR1H3 protein affects the metabolism of cholesterol|nr1h3 protein affects the transport of cholesterol,,,PMID:15725701,https://www.ncbi.nlm.nih.gov/pubmed/15725701,15725701,,
396,328208,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [cadmium chloride results in decreased expression of SQSTM1 protein],,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
397,328209,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose co-treated with cypermethrin] results in increased expression of SCD1 mrna|[lard co-treated with cholesterol co-treated with sucrose co-treated with atrazine] results in increased expression of SCD1 mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
398,328210,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,9606.0,Homo sapiens (human),SRC protein promotes the reaction [[FGF19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of cholesterol]|[fgf19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of cholesterol|dasatinib inhibits the reaction [[FGF19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of cholesterol]|nr1h4 protein results in increased export of cholesterol|nr1h4 protein mutant form inhibits the reaction [[FGF19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of cholesterol],,,PMID:30996006,https://www.ncbi.nlm.nih.gov/pubmed/30996006,30996006,,
399,328211,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,9606.0,Homo sapiens (human),NR1H4 protein affects the metabolism of cholesterol,,,PMID:12815072,https://www.ncbi.nlm.nih.gov/pubmed/12815072,12815072,,
400,328212,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,10090.0,Mus musculus (house mouse),NR1I2 protein affects the metabolism of cholesterol,,,PMID:15684063,https://www.ncbi.nlm.nih.gov/pubmed/15684063,15684063,,
401,328349,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),NR1I2 protein affects the metabolism of and results in decreased activity of and results in decreased susceptibility to cholesterol,,,PMID:15710871,https://www.ncbi.nlm.nih.gov/pubmed/15710871,15710871,,
402,328350,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,9606.0,Homo sapiens (human),Cholesterol metabolite binds to NR1I3 protein,,,PMID:16051528,https://www.ncbi.nlm.nih.gov/pubmed/16051528,16051528,,
403,328351,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,10090.0,Mus musculus (house mouse),"[1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased activity of NR1I3 protein] which results in increased abundance of cholesterol",,,PMID:22101211,https://www.ncbi.nlm.nih.gov/pubmed/22101211,22101211,,
404,328352,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9970,NR1I3,https://ctdbase.org/detail.go?type=gene&acc=9970,,,9970.0,NR1I3,10090.0,Mus musculus (house mouse),NR1I3 protein affects the metabolism of cholesterol,,,PMID:15684063,https://www.ncbi.nlm.nih.gov/pubmed/15684063,15684063,,
405,328353,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,2494,NR5A2,https://ctdbase.org/detail.go?type=gene&acc=2494,,,2494.0,NR5A2,10090.0,Mus musculus (house mouse),NR5A2 gene mutant form affects the abundance of cholesterol,,,PMID:29515023,https://www.ncbi.nlm.nih.gov/pubmed/29515023,29515023,,
406,328354,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,246730,OAS1A,https://ctdbase.org/detail.go?type=gene&acc=246730,,,246730.0,Oas1a,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of OAS1A mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
407,328355,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,243262,OAS1F,https://ctdbase.org/detail.go?type=gene&acc=243262,,,243262.0,Oas1f,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of OAS1F mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
408,328356,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4940,OAS3,https://ctdbase.org/detail.go?type=gene&acc=4940,,,4940.0,OAS3,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of OAS3 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
409,328357,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,23962,OASL2,https://ctdbase.org/detail.go?type=gene&acc=23962,,,23962.0,Oasl2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of OASL2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
410,328358,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,128506,OCSTAMP,https://ctdbase.org/detail.go?type=gene&acc=128506,,,128506.0,OCSTAMP,9606.0,Homo sapiens (human),Cholesterol results in increased expression of OCSTAMP mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
411,328534,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4973,OLR1,https://ctdbase.org/detail.go?type=gene&acc=4973,,,4973.0,OLR1,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with ergosterol] results in increased expression of OLR1 mrna|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of OLR1 protein]|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of OLR1 mrna]|[cholesterol co-treated with ergosterol] results in increased expression of OLR1 protein,,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
412,328535,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,258950,OR1J14,https://ctdbase.org/detail.go?type=gene&acc=258950,,,258950.0,Or1j14,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of OR1J14 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
413,328536,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,119695,OR52R1,https://ctdbase.org/detail.go?type=gene&acc=119695,,,119695.0,OR52R1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of OR52R1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
414,328537,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,258633,OR5W20,https://ctdbase.org/detail.go?type=gene&acc=258633,,,258633.0,Or5w20,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of OR5W20 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
415,328538,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,18407,ORM3,https://ctdbase.org/detail.go?type=gene&acc=18407,,,18407.0,Orm3,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of ORM3 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
416,328539,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9381,OTOF,https://ctdbase.org/detail.go?type=gene&acc=9381,,,9381.0,OTOF,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of OTOF mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
417,328540,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5023,P2RX1,https://ctdbase.org/detail.go?type=gene&acc=5023,,,5023.0,P2RX1,9606.0,Homo sapiens (human),Jasplakinolide inhibits the reaction [cholesterol deficiency results in decreased activity of P2RX1 protein]|cholesterol deficiency results in decreased activity of P2RX1 protein,,,PMID:21757694,https://www.ncbi.nlm.nih.gov/pubmed/21757694,21757694,,
418,328541,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5093,PCBP1,https://ctdbase.org/detail.go?type=gene&acc=5093,,,5093.0,PCBP1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of PCBP1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
419,328542,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5313,PKLR,https://ctdbase.org/detail.go?type=gene&acc=5313,,,5313.0,PKLR,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose co-treated with cypermethrin] results in increased expression of PKLR mrna|[lard co-treated with cholesterol co-treated with sucrose co-treated with atrazine] results in increased expression of PKLR mrna|[lard co-treated with cholesterol co-treated with sucrose co-treated with ethinyl estradiol] results in increased expression of PKLR mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
420,328679,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5338,PLD2,https://ctdbase.org/detail.go?type=gene&acc=5338,,,5338.0,PLD2,9606.0,Homo sapiens (human),PLD2 protein affects the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of cholesterol]]|pld2 protein inhibits the reaction [linoleic acid inhibits the reaction [APOA1 protein affects the reaction [ABCA1 protein results in increased export of cholesterol]]],,,PMID:16118212,https://www.ncbi.nlm.nih.gov/pubmed/16118212,16118212,,
421,328680,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606.0,Homo sapiens (human),PON1 protein results in decreased chemical synthesis of cholesterol,,,PMID:12615663,https://www.ncbi.nlm.nih.gov/pubmed/12615663,12615663,,
422,328681,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606.0,Homo sapiens (human),PON1 protein results in increased export of cholesterol,,,PMID:16229851|PMID:16331452,https://www.ncbi.nlm.nih.gov/pubmed/16229851|https://www.ncbi.nlm.nih.gov/pubmed/16331452,16229851|16331452,,
423,328682,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,10090.0,Mus musculus (house mouse),Cholesterol results in decreased activity of PON1 protein,,,PMID:16115471,https://www.ncbi.nlm.nih.gov/pubmed/16115471,16115471,,
424,328683,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with cholic acid] results in decreased secretion of PON1 protein|atorvastatin inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased secretion of PON1 protein]|proanthocyanidins inhibits the reaction [[cholesterol co-treated with cholic acid] results in decreased secretion of PON1 protein],,,PMID:30273964,https://www.ncbi.nlm.nih.gov/pubmed/30273964,30273964,,
425,328684,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,51246,SHISA5,https://ctdbase.org/detail.go?type=gene&acc=51246,,,51246.0,SHISA5,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of SHISA5 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
426,328685,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of cholesterol]|[pirinixic acid binds to and results in increased activity of PPARA protein] inhibits the reaction [IL1B protein results in decreased transport of cholesterol]|[bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of cholesterol]|[bezafibrate binds to and results in increased activity of PPARA protein] promotes the reaction [APOA1 protein results in increased transport of cholesterol]|[bezafibrate binds to and results in increased activity of PPARA protein] inhibits the reaction [IL1B protein results in decreased transport of cholesterol],,,PMID:12595494,https://www.ncbi.nlm.nih.gov/pubmed/12595494,12595494,,
427,328686,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
428,328687,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10036.0,Mesocricetus auratus (golden hamster),Iron-dextran complex inhibits the reaction [cholesterol results in increased expression of PPARA mrna]|cholesterol results in increased expression of PPARA mRNA,,,PMID:22570273,https://www.ncbi.nlm.nih.gov/pubmed/22570273,22570273,,
429,328842,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of PPARA mrna|atrazine promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of PPARA mrna]|ethinyl estradiol promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of PPARA mrna]|cypermethrin promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of PPARA mrna],,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
430,328843,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090.0,Mus musculus (house mouse),Cholesterol results in decreased expression of PPARA mRNA,,,PMID:25689681,https://www.ncbi.nlm.nih.gov/pubmed/25689681,25689681,,
431,328844,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090.0,Mus musculus (house mouse),PPARA affects the reaction [aspirin promotes the reaction [APOA1 affects the transport of cholesterol]],,,PMID:21088444,https://www.ncbi.nlm.nih.gov/pubmed/21088444,21088444,,
432,328845,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,9606.0,Homo sapiens (human),PPARA protein results in increased transport of cholesterol,,,PMID:16168052,https://www.ncbi.nlm.nih.gov/pubmed/16168052,16168052,,
433,328846,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of cholesterol],,,PMID:20372816,https://www.ncbi.nlm.nih.gov/pubmed/20372816,20372816,,
434,328847,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [APOA1 protein results in increased transport of cholesterol]|[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of cholesterol],,,PMID:12595494,https://www.ncbi.nlm.nih.gov/pubmed/12595494,12595494,,
435,328848,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of cholesterol|pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of cholesterol],,,PMID:12044893,https://www.ncbi.nlm.nih.gov/pubmed/12044893,12044893,,
436,328849,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606.0,Homo sapiens (human),[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased abundance of cholesterol|[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased abundance of cholesterol,,,PMID:16946405,https://www.ncbi.nlm.nih.gov/pubmed/16946405,16946405,,
437,328850,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Atrazine promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of PPARG mrna]|[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of PPARG mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
438,329001,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),Losartan inhibits the reaction [[dietary fats co-treated with cholesterol] results in increased expression of PPARG mrna]|rosiglitazone inhibits the reaction [[dietary fats co-treated with cholesterol] results in increased expression of PPARG mrna]|[dietary fats co-treated with cholesterol] results in increased expression of PPARG mRNA,,,PMID:18302760,https://www.ncbi.nlm.nih.gov/pubmed/18302760,18302760,,
439,329002,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),PPARG protein promotes the reaction [niacin promotes the reaction [APOA1 protein results in increased export of cholesterol]],,,PMID:19797938,https://www.ncbi.nlm.nih.gov/pubmed/19797938,19797938,,
440,329003,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9986.0,Oryctolagus cuniculus (rabbit),Cholesterol results in decreased expression of PPARG mrna|niacin inhibits the reaction [cholesterol results in decreased expression of PPARG mrna],,,PMID:18402819,https://www.ncbi.nlm.nih.gov/pubmed/18402819,18402819,,
441,329004,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9986.0,Oryctolagus cuniculus (rabbit),[niacin results in increased expression of PPARG mrna] which results in increased export of cholesterol,,,PMID:17395297|PMID:17963637,https://www.ncbi.nlm.nih.gov/pubmed/17395297|https://www.ncbi.nlm.nih.gov/pubmed/17963637,17395297|17963637,,
442,329005,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,648791,PPP1R3G,https://ctdbase.org/detail.go?type=gene&acc=648791,,,648791.0,PPP1R3G,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of PPP1R3G mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
443,329006,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,29968,PSAT1,https://ctdbase.org/detail.go?type=gene&acc=29968,,,29968.0,PSAT1,9606.0,Homo sapiens (human),Cholesterol results in increased expression of PSAT1 mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
444,329007,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,84722,PSRC1,https://ctdbase.org/detail.go?type=gene&acc=84722,,,84722.0,PSRC1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of PSRC1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
445,329008,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,9986.0,Oryctolagus cuniculus (rabbit),[cholesterol co-treated with estradiol] results in increased expression of PTGS2 mrna|[estradiol co-treated with PTGS2 protein] affects the susceptibility to cholesterol,,,PMID:10964725,https://www.ncbi.nlm.nih.gov/pubmed/10964725,10964725,,
446,329009,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,10090.0,Mus musculus (house mouse),Cholesterol analog affects the localization of PYCARD protein|amitriptyline inhibits the reaction [cholesterol analog affects the localization of PYCARD protein]|smpd1 protein affects the reaction [cholesterol analog affects the localization of PYCARD protein],,,PMID:28633109,https://www.ncbi.nlm.nih.gov/pubmed/28633109,28633109,,
447,329209,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of PYCARD mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
448,329210,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in increased expression of PYCARD mRNA,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
449,329211,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,29108,PYCARD,https://ctdbase.org/detail.go?type=gene&acc=29108,,,29108.0,PYCARD,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with ergosterol] results in increased expression of PYCARD mrna|[cholesterol co-treated with ergosterol] results in increased expression of PYCARD protein|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of PYCARD protein]|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of PYCARD mrna],,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
450,329212,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [simvastatin affects the localization of and results in decreased activity of RAC1 protein],,,PMID:21334995,https://www.ncbi.nlm.nih.gov/pubmed/21334995,21334995,,
451,329213,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [irbesartan results in increased expression of RAC1 mrna]|cholesterol results in increased expression of RAC1 protein|cholesterol results in increased expression of RAC1 mRNA,,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
452,329214,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,9606.0,Homo sapiens (human),[methyl-beta-cyclodextrin results in decreased abundance of cholesterol] inhibits the reaction [polystyrenes inhibits the reaction [TNF protein affects the localization of RELA protein]],,,PMID:23274767,https://www.ncbi.nlm.nih.gov/pubmed/23274767,23274767,,
453,329215,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of RELA protein|cholesterol inhibits the reaction [irbesartan results in increased expression of RELA protein],,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
454,329216,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with ergosterol] results in increased expression of RELA mrna|[cholesterol co-treated with ergosterol] results in increased expression of RELA protein|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of RELA mrna]|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of RELA protein],,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
455,329217,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,28984,RGCC,https://ctdbase.org/detail.go?type=gene&acc=28984,,,28984.0,RGCC,9606.0,Homo sapiens (human),Cholesterol results in increased expression of RGCC mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
456,329489,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,5997,RGS2,https://ctdbase.org/detail.go?type=gene&acc=5997,,,5997.0,RGS2,9606.0,Homo sapiens (human),Cholesterol results in increased degradation of RGS2 protein,,,PMID:30545937,https://www.ncbi.nlm.nih.gov/pubmed/30545937,30545937,,
457,329490,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8767,RIPK2,https://ctdbase.org/detail.go?type=gene&acc=8767,,,8767.0,RIPK2,10116.0,Rattus norvegicus (Norway rat),"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [cholesterol analog results in increased expression of RIPK2 mrna]|cholesterol analog results in increased expression of RIPK2 mrna|acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of RIPK2 mrna]",,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
458,329491,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6227,RPS21,https://ctdbase.org/detail.go?type=gene&acc=6227,,,6227.0,RPS21,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of RPS21 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
459,329492,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,9606.0,Homo sapiens (human),CYP7A1 mRNA inhibits the reaction [cholesterol results in increased phosphorylation of RPS6 protein]|cholesterol results in increased phosphorylation of RPS6 protein,,,PMID:28275691,https://www.ncbi.nlm.nih.gov/pubmed/28275691,28275691,,
460,329493,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,10090.0,Mus musculus (house mouse),Trehalose inhibits the reaction [cholesterol results in increased phosphorylation of RPS6KB1 protein]|trehalose inhibits the reaction [cholesterol inhibits the reaction [cadmium chloride results in increased cleavage of RPS6KB1 protein]]|cholesterol results in increased phosphorylation of RPS6KB1 protein,,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
461,329494,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,57521,RPTOR,https://ctdbase.org/detail.go?type=gene&acc=57521,,,57521.0,RPTOR,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of RPTOR protein,,,PMID:29486218,https://www.ncbi.nlm.nih.gov/pubmed/29486218,29486218,,
462,329495,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [cerivastatin promotes the reaction [bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
463,329496,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6257,RXRB,https://ctdbase.org/detail.go?type=gene&acc=6257,,,6257.0,RXRB,10090.0,Mus musculus (house mouse),[RXRB protein binds to NR1H2 protein] which affects the metabolism of cholesterol,,,PMID:14993927,https://www.ncbi.nlm.nih.gov/pubmed/14993927,14993927,,
464,329497,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6279,S100A8,https://ctdbase.org/detail.go?type=gene&acc=6279,,,6279.0,S100A8,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of S100A8 mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
465,329498,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6288,SAA1,https://ctdbase.org/detail.go?type=gene&acc=6288,,,6288.0,SAA1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of SAA1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
466,329637,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6289,SAA2,https://ctdbase.org/detail.go?type=gene&acc=6289,,,6289.0,SAA2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of SAA2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
467,329638,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,20210,SAA3,https://ctdbase.org/detail.go?type=gene&acc=20210,,,20210.0,Saa3,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of SAA3 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
468,329639,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,22937,SCAP,https://ctdbase.org/detail.go?type=gene&acc=22937,,,22937.0,SCAP,10029.0,Cricetulus griseus (Chinese hamster),[25-hydroxycholesterol co-treated with cholesterol] affects the localization of SCAP protein,,,PMID:27324795,https://www.ncbi.nlm.nih.gov/pubmed/27324795,27324795,,
469,329640,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,22937,SCAP,https://ctdbase.org/detail.go?type=gene&acc=22937,,,22937.0,SCAP,10029.0,Cricetulus griseus (Chinese hamster),[25-hydroxycholesterol co-treated with cholesterol] results in decreased glycosylation of SCAP protein|[25-hydroxycholesterol co-treated with cholesterol] promotes the reaction [SCAP protein binds to INSIG1 protein],,,PMID:19716478,https://www.ncbi.nlm.nih.gov/pubmed/19716478,19716478,,
470,329641,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,10090.0,Mus musculus (house mouse),[dietary fats co-treated with cholesterol] results in decreased expression of SCARB1 mrna|losartan inhibits the reaction [[dietary fats co-treated with cholesterol] results in decreased expression of SCARB1 mrna],,,PMID:18302760,https://www.ncbi.nlm.nih.gov/pubmed/18302760,18302760,,
471,329642,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,10090.0,Mus musculus (house mouse),SCARB1 protein affects the transport of cholesterol,,,PMID:26651060,https://www.ncbi.nlm.nih.gov/pubmed/26651060,26651060,,
472,329643,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,9606.0,Homo sapiens (human),SCARB1 protein affects the transport of cholesterol,,,PMID:15883047|PMID:23045399,https://www.ncbi.nlm.nih.gov/pubmed/15883047|https://www.ncbi.nlm.nih.gov/pubmed/23045399,15883047|23045399,,
473,329644,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,9606.0,Homo sapiens (human),SCARB1 protein affects the uptake of cholesterol,,,PMID:22442701,https://www.ncbi.nlm.nih.gov/pubmed/22442701,22442701,,
474,329645,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,949,SCARB1,https://ctdbase.org/detail.go?type=gene&acc=949,,,949.0,SCARB1,9606.0,Homo sapiens (human),SCARB1 protein results in increased transport of cholesterol,,,PMID:16530456,https://www.ncbi.nlm.nih.gov/pubmed/16530456,16530456,,
475,329646,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6319,SCD,https://ctdbase.org/detail.go?type=gene&acc=6319,,,6319.0,SCD,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [FGF7 protein results in increased expression of SCD mrna],,,PMID:16162944,https://www.ncbi.nlm.nih.gov/pubmed/16162944,16162944,,
476,329825,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of SCD1 mRNA,,,PMID:19260826,https://www.ncbi.nlm.nih.gov/pubmed/19260826,19260826,,
477,329826,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,10116.0,Rattus norvegicus (Norway rat),"[niacinamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased abundance of cholesterol]|[6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased activity of SIRT1 protein] inhibits the reaction [fructose results in increased abundance of cholesterol]",,,PMID:21212096,https://www.ncbi.nlm.nih.gov/pubmed/21212096,21212096,,
478,329827,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,10116.0,Rattus norvegicus (Norway rat),[cholesterol co-treated with ergosterol] results in decreased expression of SIRT1 mrna|resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in decreased expression of SIRT1 mrna],,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
479,329828,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6507,SLC1A3,https://ctdbase.org/detail.go?type=gene&acc=6507,,,6507.0,SLC1A3,9606.0,Homo sapiens (human),Cholesterol results in increased expression of SLC1A3 mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
480,329829,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,64078,SLC28A3,https://ctdbase.org/detail.go?type=gene&acc=64078,,,64078.0,SLC28A3,9606.0,Homo sapiens (human),Cholesterol results in increased expression of SLC28A3 mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
481,329830,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,10090.0,Mus musculus (house mouse),Ethinyl estradiol promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of SLC2A2 mrna]|atrazine promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of SLC2A2 mrna]|cypermethrin promotes the reaction [[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of SLC2A2 mrna]|[lard co-treated with cholesterol co-treated with sucrose] results in increased expression of SLC2A2 mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
482,329831,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6521,SLC4A1,https://ctdbase.org/detail.go?type=gene&acc=6521,,,6521.0,SLC4A1,10116.0,Rattus norvegicus (Norway rat),[hydrogen peroxide co-treated with cholesterol] affects the localization of SLC4A1 protein|benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [[hydrogen peroxide co-treated with cholesterol] affects the localization of SLC4A1 protein],,,PMID:20946910,https://www.ncbi.nlm.nih.gov/pubmed/20946910,20946910,,
483,329832,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8140,SLC7A5,https://ctdbase.org/detail.go?type=gene&acc=8140,,,8140.0,SLC7A5,9606.0,Homo sapiens (human),Cholesterol results in increased expression of SLC7A5 mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
484,329833,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of SMAD3 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
485,329978,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6609,SMPD1,https://ctdbase.org/detail.go?type=gene&acc=6609,,,6609.0,SMPD1,10090.0,Mus musculus (house mouse),SMPD1 protein affects the reaction [cholesterol analog affects the localization of NLRP3 protein]|smpd1 protein affects the reaction [cholesterol analog results in increased expression of IL1B protein]|smpd1 protein affects the reaction [cholesterol analog affects the localization of PYCARD protein]|smpd1 protein affects the reaction [cholesterol analog affects the localization of CASP1 protein]|smpd1 protein affects the reaction [cholesterol analog results in increased activity of CASP1 protein],,,PMID:28633109,https://www.ncbi.nlm.nih.gov/pubmed/28633109,28633109,,
486,329979,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,55512,SMPD3,https://ctdbase.org/detail.go?type=gene&acc=55512,,,55512.0,SMPD3,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of SMPD3 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
487,329980,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606.0,Homo sapiens (human),"[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the expression of SOD2 mrna|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] affects the expression of SOD2 mrna|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds affects the expression of SOD2 mrna]",,,PMID:35385781,https://www.ncbi.nlm.nih.gov/pubmed/35385781,35385781,,
488,329981,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6272,SORT1,https://ctdbase.org/detail.go?type=gene&acc=6272,,,6272.0,SORT1,10090.0,Mus musculus (house mouse),SORT1 protein affects the reaction [LDLR protein affects the abundance of cholesterol]|chloroquine affects the reaction [SORT1 protein affects the reaction [LDLR protein affects the abundance of cholesterol]],,,PMID:30950489,https://www.ncbi.nlm.nih.gov/pubmed/30950489,30950489,,
489,329982,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6272,SORT1,https://ctdbase.org/detail.go?type=gene&acc=6272,,,6272.0,SORT1,10090.0,Mus musculus (house mouse),SORT1 protein results in decreased abundance of cholesterol,,,PMID:25805502,https://www.ncbi.nlm.nih.gov/pubmed/25805502,25805502,,
490,329983,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,9606.0,Homo sapiens (human),Cholesterol results in increased degradation of SQLE protein|marchf6 promotes the reaction [cholesterol results in increased degradation of SQLE protein]|cholesterol inhibits the reaction [hydroxymethylglutaryl-coa reductase inhibitors results in decreased degradation of SQLE protein],,,PMID:30545937,https://www.ncbi.nlm.nih.gov/pubmed/30545937,30545937,,
491,329984,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,9606.0,Homo sapiens (human),Cholesterol results in increased expression of SQSTM1 protein,,,PMID:28275691,https://www.ncbi.nlm.nih.gov/pubmed/28275691,28275691,,
492,329985,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714.0,SRC,9606.0,Homo sapiens (human),SRC protein promotes the reaction [[FGF19 protein results in increased phosphorylation of NR1H4 protein] which results in increased export of cholesterol],,,PMID:30996006,https://www.ncbi.nlm.nih.gov/pubmed/30996006,30996006,,
493,330132,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,9606.0,Homo sapiens (human),[25-hydroxycholesterol co-treated with cholesterol] results in decreased cleavage of SREBF1 protein,,,PMID:27324795,https://www.ncbi.nlm.nih.gov/pubmed/27324795,27324795,,
494,330133,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6720,SREBF1,https://ctdbase.org/detail.go?type=gene&acc=6720,,,6720.0,SREBF1,10090.0,Mus musculus (house mouse),[lard co-treated with cholesterol co-treated with sucrose co-treated with ethinyl estradiol] results in increased expression of SREBF1 mrna|[lard co-treated with cholesterol co-treated with sucrose co-treated with atrazine] results in increased expression of SREBF1 mRNA,,,PMID:24440342,https://www.ncbi.nlm.nih.gov/pubmed/24440342,24440342,,
495,330134,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,9606.0,Homo sapiens (human),[25-hydroxycholesterol co-treated with cholesterol] results in decreased cleavage of SREBF2 protein,,,PMID:27324795,https://www.ncbi.nlm.nih.gov/pubmed/27324795,27324795,,
496,330135,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,9606.0,Homo sapiens (human),SREBF2 protein results in increased abundance of cholesterol|betadex inhibits the reaction [SREBF2 protein results in increased abundance of cholesterol]|srebf2 protein affects the reaction [lipopolysaccharides results in increased abundance of cholesterol],,,PMID:33677747,https://www.ncbi.nlm.nih.gov/pubmed/33677747,33677747,,
497,330136,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,9606.0,Homo sapiens (human),SREBF2 promotes the reaction [bisphenol A results in increased import of cholesterol],,,PMID:28057006,https://www.ncbi.nlm.nih.gov/pubmed/28057006,28057006,,
498,330137,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,9606.0,Homo sapiens (human),[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased abundance of cholesterol|srebf2 protein affects the abundance of cholesterol,,,PMID:16946405,https://www.ncbi.nlm.nih.gov/pubmed/16946405,16946405,,
499,330138,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6721,SREBF2,https://ctdbase.org/detail.go?type=gene&acc=6721,,,6721.0,SREBF2,10116.0,Rattus norvegicus (Norway rat),Cholesterol inhibits the reaction [[cholesterol deficiency co-treated with lovastatin] results in increased activity of SREBF2 protein]|[cholesterol deficiency co-treated with lovastatin] results in increased activity of SREBF2 protein,,,PMID:20578043,https://www.ncbi.nlm.nih.gov/pubmed/20578043,20578043,,
500,330139,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9606.0,Homo sapiens (human),STAR protein affects the transport of cholesterol,,,PMID:15819722,https://www.ncbi.nlm.nih.gov/pubmed/15819722,15819722,,
501,330140,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9606.0,Homo sapiens (human),STAR protein results in increased transport of cholesterol,,,PMID:19900470,https://www.ncbi.nlm.nih.gov/pubmed/19900470,19900470,,
502,330141,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10090.0,Mus musculus (house mouse),27-hydroxycholesterol promotes the reaction [STAR protein promotes the reaction [[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol]]|star protein promotes the reaction [[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol]|probucol inhibits the reaction [STAR protein promotes the reaction [[bucladesine co-treated with APOA1 protein] results in increased secretion of cholesterol]],,,PMID:20083572,https://www.ncbi.nlm.nih.gov/pubmed/20083572,20083572,,
503,330301,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10090.0,Mus musculus (house mouse),STAR protein affects the transport of cholesterol,,,PMID:14630719,https://www.ncbi.nlm.nih.gov/pubmed/14630719,14630719,,
504,330302,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116.0,Rattus norvegicus (Norway rat),Cholesterol inhibits the reaction [bisphenol A results in increased expression of STAR protein]|cholesterol inhibits the reaction [bisphenol A results in increased expression of STAR mrna],,,PMID:28859904,https://www.ncbi.nlm.nih.gov/pubmed/28859904,28859904,,
505,330303,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,10116.0,Rattus norvegicus (Norway rat),STAR protein results in increased export of cholesterol|[[niacin co-treated with chromium] results in increased expression of STAR protein] which results in increased export of cholesterol,,,PMID:17934701,https://www.ncbi.nlm.nih.gov/pubmed/17934701,17934701,,
506,330304,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9606.0,Homo sapiens (human),STAR protein affects the localization of cholesterol,,,PMID:12530643|PMID:16469751,https://www.ncbi.nlm.nih.gov/pubmed/12530643|https://www.ncbi.nlm.nih.gov/pubmed/16469751,12530643|16469751,,
507,330305,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6770,STAR,https://ctdbase.org/detail.go?type=gene&acc=6770,,,6770.0,STAR,9606.0,Homo sapiens (human),STAR protein results in increased metabolism of cholesterol,,,PMID:15713539,https://www.ncbi.nlm.nih.gov/pubmed/15713539,15713539,,
508,330306,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of STAT1 protein,,,PMID:17507688,https://www.ncbi.nlm.nih.gov/pubmed/17507688,17507688,,
509,330307,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,100135887,STAT5,https://ctdbase.org/detail.go?type=gene&acc=100135887,,,100135887.0,,10090.0,Mus musculus (house mouse),Cholesterol inhibits the reaction [nicotine results in decreased phosphorylation of STAT5 protein],,,PMID:31629012,https://www.ncbi.nlm.nih.gov/pubmed/31629012,31629012,,
510,330308,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,172846,STRL-1,https://ctdbase.org/detail.go?type=gene&acc=172846,,,172846.0,strl-1,6239.0,Caenorhabditis elegans,Cholesterol inhibits the reaction [bisphenol A results in increased expression of STRL-1 mrna],,,PMID:31445225,https://www.ncbi.nlm.nih.gov/pubmed/31445225,31445225,,
511,330309,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9900,SV2A,https://ctdbase.org/detail.go?type=gene&acc=9900,,,9900.0,SV2A,10090.0,Mus musculus (house mouse),"[methyl-beta-cyclodextrin results in decreased abundance of cholesterol] promotes the reaction [SV2A protein binds to botulinum toxins, type A]",,,PMID:28645175,https://www.ncbi.nlm.nih.gov/pubmed/28645175,28645175,,
512,330310,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,11346,SYNPO,https://ctdbase.org/detail.go?type=gene&acc=11346,,,11346.0,SYNPO,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of SYNPO mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
513,330459,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,338811,TAFA2,https://ctdbase.org/detail.go?type=gene&acc=338811,,,338811.0,TAFA2,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of TAFA2 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
514,330460,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,339488,TFAP2E,https://ctdbase.org/detail.go?type=gene&acc=339488,,,339488.0,TFAP2E,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of TFAP2E mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
515,330461,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7033,TFF3,https://ctdbase.org/detail.go?type=gene&acc=7033,,,7033.0,TFF3,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of TFF3 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
516,330462,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of TGFB1 mRNA,,,PMID:19110552,https://www.ncbi.nlm.nih.gov/pubmed/19110552,19110552,,
517,330463,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of TGFB1 mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
518,330464,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,21822,TGTP1,https://ctdbase.org/detail.go?type=gene&acc=21822,,,21822.0,Tgtp1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of TGTP1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
519,330465,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7078,TIMP3,https://ctdbase.org/detail.go?type=gene&acc=7078,,,7078.0,TIMP3,9606.0,Homo sapiens (human),Cholesterol results in increased expression of TIMP3 mrna|clec4e protein inhibits the reaction [cholesterol results in increased expression of TIMP3 mrna],,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
520,330466,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of TLR4 mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
521,330467,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,116211,TM4SF19,https://ctdbase.org/detail.go?type=gene&acc=116211,,,116211.0,TM4SF19,9606.0,Homo sapiens (human),Cholesterol results in increased expression of TM4SF19 mRNA,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
522,330468,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,27346,TMEM97,https://ctdbase.org/detail.go?type=gene&acc=27346,,,27346.0,TMEM97,9606.0,Homo sapiens (human),TMEM97 protein affects the metabolism of cholesterol,,,PMID:18070364,https://www.ncbi.nlm.nih.gov/pubmed/18070364,18070364,,
523,330631,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[cholesterol co-treated with CLEC4E] results in increased expression of TNF protein,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,
524,330632,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[methyl-beta-cyclodextrin results in decreased abundance of cholesterol] inhibits the reaction [polystyrenes inhibits the reaction [TNF protein affects the localization of RELA protein]]|[methyl-beta-cyclodextrin results in decreased abundance of cholesterol] inhibits the reaction [polystyrenes inhibits the reaction [TNF protein results in increased expression of CXCL8 mrna]],,,PMID:23274767,https://www.ncbi.nlm.nih.gov/pubmed/23274767,23274767,,
525,330633,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of TNF protein|cholesterol results in increased expression of TNF mrna|cholesterol inhibits the reaction [irbesartan results in increased expression of TNF mrna]|cholesterol inhibits the reaction [irbesartan results in increased expression of TNF protein],,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
526,330634,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in increased expression of TNF mrna|acetylcysteine inhibits the reaction [cholesterol analog results in increased expression of TNF mrna],,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
527,330635,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Cholesterol promotes the reaction [particulate matter results in increased expression of TNF protein]|alpha-linolenic acid inhibits the reaction [cholesterol promotes the reaction [particulate matter results in increased expression of TNF protein]]|[cholesterol co-treated with particulate matter] results in increased expression of TNF mRNA,,,PMID:30672636,https://www.ncbi.nlm.nih.gov/pubmed/30672636,30672636,,
528,330636,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of TNF mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
529,330637,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7132,TNFRSF1A,https://ctdbase.org/detail.go?type=gene&acc=7132,,,7132.0,TNFRSF1A,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in increased expression of TNFRSF1A protein,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
530,330638,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in increased expression of TNFSF10 protein|cholesterol analog results in increased expression of TNFSF10 mRNA,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
531,330639,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),"[[EGF protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] affects the reaction [silver compounds affects the expression of TP53 mrna]|[[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] co-treated with silver compounds] results in decreased expression of TP53 mrna|[[egf protein binds to 1,2-dioleoyl-3-phosphoethanolamine-n-(poly(ethyleneglycol))-hydroxy succinamide] co-treated with [1,2-distearoyllecithin co-treated with cholesterol co-treated with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)]] results in increased expression of TP53 mRNA",,,PMID:35385781,https://www.ncbi.nlm.nih.gov/pubmed/35385781,35385781,,
532,330796,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7185,TRAF1,https://ctdbase.org/detail.go?type=gene&acc=7185,,,7185.0,TRAF1,10116.0,Rattus norvegicus (Norway rat),Cholesterol analog results in increased expression of TRAF1 mRNA,,,PMID:19477266,https://www.ncbi.nlm.nih.gov/pubmed/19477266,19477266,,
533,330797,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,57761,TRIB3,https://ctdbase.org/detail.go?type=gene&acc=57761,,,57761.0,TRIB3,10090.0,Mus musculus (house mouse),TRIB3 protein results in increased abundance of and results in increased secretion of cholesterol,,,PMID:32929351,https://www.ncbi.nlm.nih.gov/pubmed/32929351,32929351,,
534,330798,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,10537,UBD,https://ctdbase.org/detail.go?type=gene&acc=10537,,,10537.0,UBD,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of UBD mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
535,330799,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7329,UBE2I,https://ctdbase.org/detail.go?type=gene&acc=7329,,,7329.0,UBE2I,9606.0,Homo sapiens (human),UBE2I protein inhibits the reaction [lipopolysaccharides results in increased abundance of cholesterol],,,PMID:33677747,https://www.ncbi.nlm.nih.gov/pubmed/33677747,33677747,,
536,330800,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,10090.0,Mus musculus (house mouse),Cholesterol results in increased expression of VCAM1 mrna|cholesterol results in increased expression of VCAM1 protein|cholesterol inhibits the reaction [irbesartan results in increased expression of VCAM1 mrna]|cholesterol inhibits the reaction [irbesartan results in increased expression of VCAM1 protein],,,PMID:19028402,https://www.ncbi.nlm.nih.gov/pubmed/19028402,19028402,,
537,330801,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,10116.0,Rattus norvegicus (Norway rat),[cocoa butter co-treated with sodium cholate co-treated with cholesterol] results in increased expression of VCAM1 mRNA,,,PMID:26606054,https://www.ncbi.nlm.nih.gov/pubmed/26606054,26606054,,
538,330802,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7421,VDR,https://ctdbase.org/detail.go?type=gene&acc=7421,,,7421.0,VDR,9606.0,Homo sapiens (human),Cholesterol metabolite binds to VDR protein,,,PMID:16051528,https://www.ncbi.nlm.nih.gov/pubmed/16051528,16051528,,
539,330803,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7421,VDR,https://ctdbase.org/detail.go?type=gene&acc=7421,,,7421.0,VDR,9606.0,Homo sapiens (human),VDR gene SNP affects the abundance of cholesterol,,,PMID:25498546,https://www.ncbi.nlm.nih.gov/pubmed/25498546,25498546,,
540,330804,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10116.0,Rattus norvegicus (Norway rat),"[1,2-dioleoyloxy-3-(trimethylammonium)propane co-treated with cholesterol] results in increased expression of VEGFA protein",,,PMID:16034455,https://www.ncbi.nlm.nih.gov/pubmed/16034455,16034455,,
541,330805,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7431,VIM,https://ctdbase.org/detail.go?type=gene&acc=7431,,,7431.0,VIM,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [arachidonyl dopamine results in decreased expression of VIM mrna],,,PMID:33393692,https://www.ncbi.nlm.nih.gov/pubmed/33393692,33393692,,
542,330989,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,7450,VWF,https://ctdbase.org/detail.go?type=gene&acc=7450,,,7450.0,VWF,10116.0,Rattus norvegicus (Norway rat),Resveratrol inhibits the reaction [[cholesterol co-treated with ergosterol] results in increased expression of and results in increased secretion of VWF protein]|[cholesterol co-treated with ergosterol] results in increased expression of and results in increased secretion of VWF protein,,,PMID:25833014,https://www.ncbi.nlm.nih.gov/pubmed/25833014,25833014,,
543,330990,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,81030,ZBP1,https://ctdbase.org/detail.go?type=gene&acc=81030,,,81030.0,ZBP1,10090.0,Mus musculus (house mouse),"[cholesterol co-treated with 1,2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of ZBP1 mRNA",,,PMID:22129739,https://www.ncbi.nlm.nih.gov/pubmed/22129739,22129739,,
544,330991,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,6935,ZEB1,https://ctdbase.org/detail.go?type=gene&acc=6935,,,6935.0,ZEB1,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [arachidonyl dopamine results in decreased expression of ZEB1 mrna],,,PMID:33393692,https://www.ncbi.nlm.nih.gov/pubmed/33393692,33393692,,
545,330992,5997,Comparative Toxicogenomics Database (CTD),Cholesterol,D002784,Cholesterol,https://ctdbase.org/detail.go?type=chem&acc=D002784,9839,ZEB2,https://ctdbase.org/detail.go?type=gene&acc=9839,,,9839.0,ZEB2,9606.0,Homo sapiens (human),Cholesterol inhibits the reaction [arachidonyl dopamine results in decreased expression of ZEB2 mrna],,,PMID:33393692,https://www.ncbi.nlm.nih.gov/pubmed/33393692,33393692,,
546,519359,5997,BindingDB,Cholesterol,20192,"(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20192,2051,Oxysterols receptor LXR-alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2051,Q13133,Oxysterols receptor LXR-alpha,10062.0,NR1H3,9606.0,Homo sapiens (human),,,,PMID:11300870,https://www.ncbi.nlm.nih.gov/pubmed/11300870,11300870,,
547,542466,5997,BindingDB,Cholesterol,20192,"(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20192,5176,Cytochrome P450 125 (CYP125),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5176,P9WPP0,Steroid C26-monooxygenase,,,83331.0,Mycobacterium tuberculosis CDC1551,,,,PMID:20889498,https://www.ncbi.nlm.nih.gov/pubmed/20889498,20889498,,
548,542467,5997,BindingDB,Cholesterol,20192,"(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20192,5177,Cytochrome P450 142 (CYP142),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5177,P9WPL4,Steroid C26-monooxygenase,,,83331.0,Mycobacterium tuberculosis CDC1551,,,,PMID:20889498,https://www.ncbi.nlm.nih.gov/pubmed/20889498,20889498,,
549,576949,5997,IUPHAR/BPS Guide to PHARMACOLOGY,Cholesterol,2718,cholesterol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2718,598,RAR-related orphan receptor-,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=598,P35398,Nuclear receptor ROR-alpha,6095.0,RORA,9606.0,Homo sapiens (human),Agonist,,5.42,PMID:8858107|PMID:12467577,https://www.ncbi.nlm.nih.gov/pubmed/8858107|https://www.ncbi.nlm.nih.gov/pubmed/12467577,8858107|12467577,,
550,576950,5997,Drug Gene Interaction database (DGIdb),Cholesterol,,CHOLESTEROL,https://www.dgidb.org/drugs/CHOLESTEROL,,NFE2L2,https://www.dgidb.org/genes/NFE2L2,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),,,,,,,,
551,597125,5997,Drug Gene Interaction database (DGIdb),Cholesterol,,CHOLESTEROL,https://www.dgidb.org/drugs/CHOLESTEROL,,RORA,https://www.dgidb.org/genes/RORA,,,6095.0,RORA,9606.0,Homo sapiens (human),Agonist,,,,,,,
552,605779,5997,Therapeutic Target Database (TTD),Cholesterol,D02DLW,Cholesterol,https://idrblab.net/ttd/data/drug/details/D02DLW,T95998,Cholinephosphate cytidylyltransferase (PCYT1B),https://idrblab.net/ttd/data/target/details/T95998,Q9Y5K3,Choline-phosphate cytidylyltransferase B,9468.0,PCYT1B,9606.0,Homo sapiens (human),Activator,,,,,,,
553,1143360,5997,BindingDB,Cholesterol,20192,"(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20192,9818,OSBP-related protein 4 (ORP4L),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9818,Q969R2,Oxysterol-binding protein 2,23762.0,OSBP2,9606.0,Homo sapiens (human),,,,PMID:24742681,https://www.ncbi.nlm.nih.gov/pubmed/24742681,24742681,,
554,1143361,5997,BindingDB,Cholesterol,20192,"(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20192,9819,OSBP-related protein 4 (ORP4S),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9819,,,,,,,,,,PMID:24742681,https://www.ncbi.nlm.nih.gov/pubmed/24742681,24742681,,
555,1617128,5997,DrugBank,Cholesterol,DB04540,Cholesterol,https://www.drugbank.ca/drugs/DB04540,BE0003848,Nuclear receptor subfamily 1 group I member 3,https://www.drugbank.ca/bio_entities/BE0003848,Q14994,Nuclear receptor subfamily 1 group I member 3 ,9970.0,NR1I3,9606.0,Homo sapiens (human),,,,PMID:16051528,https://www.ncbi.nlm.nih.gov/pubmed/16051528,16051528,,"Mooijaart SP, Brandt BW, Baldal EA, Pijpe J, Kuningas M, Beekman M, Zwaan BJ, Slagboom PE, Westendorp RG, van Heemst D: C. elegans DAF-12, Nuclear Hormone Receptors and human longevity and disease at old age. Ageing Res Rev. 2005 Aug;4(3):351-71."
556,1617129,5997,DrugBank,Cholesterol,DB04540,Cholesterol,https://www.drugbank.ca/drugs/DB04540,BE0000779,Vitamin D3 receptor,https://www.drugbank.ca/bio_entities/BE0000779,P11473,Vitamin D3 receptor,7421.0,VDR,9606.0,Homo sapiens (human),,,,PMID:16051528,https://www.ncbi.nlm.nih.gov/pubmed/16051528,16051528,,"Mooijaart SP, Brandt BW, Baldal EA, Pijpe J, Kuningas M, Beekman M, Zwaan BJ, Slagboom PE, Westendorp RG, van Heemst D: C. elegans DAF-12, Nuclear Hormone Receptors and human longevity and disease at old age. Ageing Res Rev. 2005 Aug;4(3):351-71."
557,1617130,5997,DrugBank,Cholesterol,DB04540,Cholesterol,https://www.drugbank.ca/drugs/DB04540,BE0009096,C-type lectin domain family 4 member E,https://www.drugbank.ca/bio_entities/BE0009096,Q9ULY5,C-type lectin domain family 4 member E,26253.0,CLEC4E,9606.0,Homo sapiens (human),Ligand,,,PMID:26296894,https://www.ncbi.nlm.nih.gov/pubmed/26296894,26296894,,"Kiyotake R, Oh-Hora M, Ishikawa E, Miyamoto T, Ishibashi T, Yamasaki S: Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses. J Biol Chem. 2015 Oct 16;290(42):25322-32. doi: 10.1074/jbc.M115.645234. Epub 2015 Aug 20."
558,1617131,5997,DrugBank,Cholesterol,DB04540,Cholesterol,https://www.drugbank.ca/drugs/DB04540,BE0004545,Nuclear receptor ROR-alpha,https://www.drugbank.ca/bio_entities/BE0004545,P35398,Nuclear receptor ROR-alpha,6095.0,RORA,9606.0,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,"Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.|Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.|Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
559,1617132,5997,DrugBank,Cholesterol,DB04540,Cholesterol,https://www.drugbank.ca/drugs/DB04540,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11027568,https://www.ncbi.nlm.nih.gov/pubmed/11027568,11027568,,"Wang E, Casciano CN, Clement RP, Johnson WW: Cholesterol interaction with the daunorubicin binding site of P-glycoprotein. Biochem Biophys Res Commun. 2000 Oct 5;276(3):909-16."
560,1617471,5997,DrugBank,Cholesterol,DB04540,Cholesterol,https://www.drugbank.ca/drugs/DB04540,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Inducer,,,PMID:12668685,https://www.ncbi.nlm.nih.gov/pubmed/12668685,12668685,,"Janvilisri T, Venter H, Shahi S, Reuter G, Balakrishnan L, van Veen HW: Sterol transport by the human breast cancer resistance protein (ABCG2) expressed in Lactococcus lactis. J Biol Chem. 2003 Jun 6;278(23):20645-51. Epub 2003 Mar 28."
561,1657163,5997,BindingDB,Cholesterol,20192,"(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20192,8781,Tryptophan-rich sensory protein/translocator protein (TSPO),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8781,,,,,,,,,,PMID:27990801,https://www.ncbi.nlm.nih.gov/pubmed/27990801,27990801,,
562,1657164,5997,BindingDB,Cholesterol,20192,"(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20192,8781,Tryptophan-rich sensory protein/translocator protein (TSPO),https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=8781,,,,,,,,,,PMID:27990801,https://www.ncbi.nlm.nih.gov/pubmed/27990801,27990801,,
